nandrolone has been researched along with dienogest in 374 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 51 (13.64) | 18.7374 |
| 1990's | 25 (6.68) | 18.2507 |
| 2000's | 71 (18.98) | 29.6817 |
| 2010's | 167 (44.65) | 24.3611 |
| 2020's | 60 (16.04) | 2.80 |
| Authors | Studies |
|---|---|
| Das, RP; Sharma, RK | 2 |
| Boer, J; Carol, W; Klinger, G; Michels, W; Pocha, C | 1 |
| Buchmann, J; Kaltwasser, P; Rothe, K; Schneider, F; Seliger, E | 1 |
| Band, V; Farooq, A; Kharbanda, SM; Murugesan, K | 1 |
| Bhatti, DP; Chaudhary, J; Das, RP; Majumdar, SS; Misro, MM; Sharma, RK | 1 |
| Balogh, A; Hoffmann, A; Klinger, G; Liewald, S; Liewald, T; Schröder, S; Splinter, FC | 1 |
| Chaudhary, J; Das, RP; Majumdar, SS; Sharma, RK | 1 |
| Gupta, G; Setty, BS; Srivastava, A | 1 |
| Hillesheim, HG; Hobe, G; Ritter, P; Valentin, U | 1 |
| Hillesheim, HG; Hobe, G; Ritter, P; Schade, W; Schön, R; Wehrberger, K | 1 |
| Brachmann, K; Göretzlehner, G; Köhler, G | 1 |
| Köhler, G; Männchen, E; Nikschick, S | 1 |
| Carol, W; Jäger, R; Martin, P; Möller, U | 1 |
| Brachmann, K; Foth, D; Happke, S; Köhler, G; Lembke, S | 1 |
| Farooq, A; Kalita, JC; Murugesan, K; Vij, U | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Band, V; Bhargava, VL; Farooq, A; Kharbanda, SM; Murugesan, K; Verma, U | 1 |
| Ahrendt, HJ; Amon, I; Canzler, E; Köhler, G; Lembke, S | 1 |
| Das, RP; Majumdar, SS; Sharma, RK | 1 |
| Maikhuri, JP; Setty, BS; Srivastava, A | 1 |
| Erdmann, A; Hobe, G; Klinger, G; Reddersen, G | 1 |
| Amon, I; Göretzlehner, G; Köhler, G | 1 |
| Frankenberg, G; Hobe, G; Hübner, M; Menzenbach, B; Reddersen, G; Römer, J; Schubert, K; Wagner, H; Wesemann, R | 1 |
| Hieu, DK; Hobe, G; Reddersen, G; Wehrberger, K | 1 |
| Jemilev, ZA; Komor, A; Schubert, K; Strecke, J | 1 |
| Koch, M; Peschke, T; Stracke, R | 1 |
| Lisse, K; Schürenkämper, P | 1 |
| Freund, H; Freund, R; Kurischko, A; Meyer, M; Oettel, M; Stölzner, W | 1 |
| Eychenne, B; Kaufmann, G; Schlegel, J; Schubert, K | 1 |
| Becker, K; Braun, R; Schöneich, J | 1 |
| Freund, H; Koch, M; Kurischko, A; Oettel, M; Römer, W; Stölzner, W; Stracke, R; Strecke, J | 1 |
| Chemnitius, KH; Dietz, K; Freund, H; Hesse, G; Oettel, M; Raj, MH; Stölzner, W | 1 |
| Härtl, A; Hillesheim, HG; Hoffmann, H; Kirchner, E; Knappe, H; Tkocz, R | 1 |
| Hillesheim, HG; Hoffmann, H | 1 |
| Anke, M; Chemnitius, KH; Dettmann, R; Deufrains, J; Furcht, R; Gaida, P; Güttner, J; Hesse, G; Hesse, V; Hillesheim, HG; Hoffmann, H; Holle, K; Horn, U; Keil, E; Klinger, G; Kramp, B; Lemke, H; Merbt, EM; Oettel, M; Robiller, F; Schimmel, I; Selzner, A; Stade, K; Strecke, J; Valentin, U | 1 |
| Goncharov, NP; Komor, A; Oettel, M; Schubert, K | 1 |
| Koch, M | 1 |
| Göretzlehner, G; Köhler, G; Kunkel, S; Meissner, J; Rudolf, K; Rüting, M; Schollberg, K | 1 |
| Bräuer, R; Chemnitius, KH; Grass, M | 1 |
| Das, RP; Warikoo, PK | 1 |
| Frankenberg, G; Hobe, G; Schade, W; Schön, R; Schubert, K | 1 |
| Oettel, M; Ponsold, K; Schubert, K | 1 |
| Hübner, M; Ponsold, K | 1 |
| Carol, W; Chemnitius, KH; Claussen, C; Erdmann, A; Goncharov, NP; Hillesheim, HG; Hobe, G; Klinger, G; Komor, A; Ritter, P; Schumann, W; Wagner, H; Wehrberger, K; Wesemann, R | 1 |
| Hobe, G; Hörhold, C; Kaufmann, G; Schubert, K; Schumann, G; Wehrberger, K | 1 |
| Klaus, S | 1 |
| Heinecke, H; Köhler, D | 1 |
| Kaufmann, G; Schubert, K; Schumann, G | 1 |
| Hesse, G; Kurischko, A; Löw, O; Oettel, M; Tkocz, H | 1 |
| Jemilev, ZA; Komor, A; Oettel, M; Schubert, K; Strecke, J | 1 |
| Güttner, J; Hillesheim, HG; Hoffmann, H; Oettel, M | 1 |
| Goncharov, NP; Komor, A; Oettel, M | 1 |
| Hillesheim, HG; Hoffmann, H; Oettel, M; Strecke, J | 1 |
| Koch, M; Kurischko, A; Oettel, M; Strecke, J | 1 |
| Hobe, G; Hörhold, C; Hübner, M; Schade, W; Schön, R; Schubert, K | 1 |
| Castracane, VD; Goldzieher, JW | 1 |
| Kurischko, A; Oettel, M | 1 |
| Kaufmann, G; Kurischko, A; Oettel, M | 1 |
| Aoki, D; Katsuki, Y; Nozawa, S; Shibutani, Y | 1 |
| Aoki, D; Katsuki, Y; Nozawa, S; Sasagawa, S; Shibutani, Y; Takano, Y; Udagawa, Y | 1 |
| Feichtinger, W; Gräser, T; Kindermann, C; Mellinger, U; Moore, C; Schneider, B; Spona, J; Walter, F | 1 |
| Feichtinger, W; Gräser, T; Kindermann, C; Mellinger, U; Moore, C; Spona, J; Walter, F | 1 |
| Carol, W; Gräser, T; Klinger, G; Mellinger, U; Moore, C; Oettel, M; Schindler, AE; Winkler, UH | 1 |
| Aoki, D; Futamura, Y; Katsuki, Y; Nozawa, S; Shibutani, Y; Takano, Y; Udagawa, Y | 1 |
| Glusa, E; Gräser, T; Oettel, M; Wagner, S | 1 |
| Eick, S; Gräser, T; Klinger, G; Moore, C; Oettel, M; Pfister, W | 1 |
| Hamada, Y; Ishikawa, T; Katsuki, Y; Nobukata, H; Sato, M; Shibutani, Y | 1 |
| Foster, RH; Wilde, MI | 1 |
| Inokuma, M; Ishikawa, T; Katsuki, Y; Nobukata, H; Shibutani, Y | 1 |
| Chakravarty, S; Singh, SK | 1 |
| Christensen, B; Henkel, A; Schindler, AE | 1 |
| Dautzenberg, H; Henkel, H; Kaufmann, G; Müller, G; Oettel, M; Schäfer, T; Undeutsch, B | 1 |
| Dietrich, H; Hoffmann, H; Wisser, KH; Zimmermann, T | 1 |
| Katsuki, Y; Nakamura, M; Oikawa, T; Shibutani, Y | 1 |
| Gräser, T; Groh, A; Klinger, G; Latterman, C; Mellinger, U; Moore, C; Vogelsang, H | 1 |
| Gräser, T; Lippert, TH; Mellinger, U; Mück, AO; Müller, A; Oettel, M | 1 |
| Glänzer, S; Klinger, G; Römer, W; Sigusch, B | 1 |
| Hamada, Y; Inoue, S; Ishikawa, T; Kakinuma, C; Kuwayama, C; Shibutani, Y | 1 |
| Kowald, A; Ortmann, J; Rabe, T; Rehberger-Schneider, S | 1 |
| Balogh, A; Gräser, G; Kauf, E; Klinger, G; Oettel, M; Vollanth, R | 1 |
| Kanzaki, H; Nakajima, T; Okada, H; Yasuda, K; Yoshimura, T | 1 |
| Böck, G; Gräser, T; Gruber, D; Grünberger, J; Huber, J; Linzmayer, L; Metka, M; Oettel, M; Saletu, B; Saletu-Zyhlarz, G; Semlitsch, HV; Zoghlami, A | 1 |
| Hobe, G; Jäger, R; Klinger, G; Küntzel, B; Piater, T; Schön, R | 1 |
| Gräser, T; Lüdtke, R; Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Skouby, SO | 1 |
| Schneider, HP | 1 |
| Drapier-Faure, E; Faure, M | 1 |
| Fiegler, P; Kamiński, K; Marr, J; Moore, C | 1 |
| Fiegler, P; Gabryś, J; Kamiński, K; Kozielski, J | 1 |
| Meczekalski, B; Słopień, R; Warenik-Szymankiewicz, A | 1 |
| Gräser, T; Lippert, TH; Mueck, AO; Oettel, M; Seeger, H | 1 |
| Gräser, T; Janaud, A; Römer, T; Wiedey, KD | 1 |
| Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
| Bauer, HH; Gross, W; Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; von Hayn, C; Wiegratz, I; Winkler, UH | 1 |
| Audebert, A; Cosson, M; Donnez, J; Konincks, P; Madelenat, P; Manhes, H; Querleu, D | 1 |
| Bertaccini, A; Bremner, WJ; Costantino, A; Flamigni, C; Huebler, D; Kaufmann, G; Meriggiola, MC; Morselli-Labate, AM; Oettel, M | 1 |
| Domschke, W; Heinig, J; Lerch, MM; Simon, P; Weiss, FU; Zimmer, KP | 1 |
| Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 2 |
| Anderer, P; Gruber, D; Huber, J; Metka, M; Saletu, B; Saletu-Zyhlarz, GM | 1 |
| Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; Wiegratz, I; Winkler, UH | 2 |
| Anderer, P; Gräser, T; Gruber, D; Huber, J; Metka, M; Oettel, M; Saletu, B; Saletu-Zyhlarz, G; Semlitsch, HV | 1 |
| Rabe, T; Raudrant, D | 1 |
| Domhardt, R; Golbs, S; Kałuzny, Z; Radowicky, S; Wisser, KH; Zimmermann, T | 1 |
| Domhardt, R; Ganev, M; Golbs, S; Presl, J; Wisser, KH; Zimmermann, T | 1 |
| Breckwoldt, M | 1 |
| Kamischke, A; Nieschlag, E; Zitzmann, M | 1 |
| Sitruk-Ware, R | 1 |
| Teichmann, A | 1 |
| von Schoultz, B | 1 |
| Saletu, B | 1 |
| Borakowska, B; Radowicki, S; Skórzewska, K | 1 |
| Hommel, HH; Kuhl, H; Wiegratz, I; Zimmermann, T | 1 |
| Azavedo, E; Carlström, K; Conner, P; Gräser, T; Söderqvist, G; Svane, G; von Schoultz, B; Walter, F | 1 |
| Kuhl, H; Kutschera, E; Lee, JH; Wiegratz, I; Winkler, UH | 1 |
| Brambilla, G; Carrozzino, R; Garbero, C; Gosmar, M; Manfredi, V; Martelli, A; Mattioli, F | 1 |
| Breitbarth, H; Gräser, T; Kirsch, B; Mellinger, U; Palombo-Kinne, E; Rudolph, I | 1 |
| Fushiki, S; Hirasugi, Y; Honjo, H; Hosoda, T; Iwasa, K; Kawata, M; Kikuchi, N; Kitawaki, J; Mihara, M; Oida, N; Tatsumi, H; Yamamoto, H | 1 |
| Costantino, A; De Lasio, R; Gambineri, A; Meriggiola, MC; Pagotto, U; Pasquali, R; Patton, L; Pelusi, C; Pelusi, G | 1 |
| Godekmerdan, A; Kumru, S; Kutlu, S; Yildiz, MF | 1 |
| Aygun, E; Dansuk, R; Kucukercan, I; Pirimoglu, ZM; Turan, C; Unal, O | 1 |
| Christensen, B; Henkel, A; Moore, C; Oettel, M; Schindler, AE | 2 |
| Dietrich, H; Kuhl, H; Mittmann, K; Wiegratz, I; Zimmermann, T | 1 |
| Atasaral, T; Baltaci, D; Bozkaya, H; Osmanağaoğlu, MA | 1 |
| Fu, L; Hirata, T; Hirota, Y; Morimoto, C; Osuga, Y; Taketani, Y; Yano, T | 1 |
| Endrikat, J; Graeser, T; Kunz, M; Lange, E; Schmidt, W | 1 |
| Endrikat, J; Ertan, K; Graeser, T; Holz, C; Mellinger, U | 1 |
| Emons, G; Faber, M; Günthert, AR; Hellriegel, S; Knappe, G | 1 |
| Imada, K; Kami, H; Kato, S; Mita, S; Mizuguchi, K; Sasagawa, S; Shimizu, Y; Takeuchi, T | 1 |
| Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Sänger, N; Stahlberg, S; Wiegratz, I | 2 |
| Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A | 1 |
| Aso, T; Fukunaga, M; Hagino, H; Harada, T; Momoeda, M; Taketani, Y; Terakawa, N | 2 |
| Duijkers, I; Endrikat, J; Klipping, C; Parke, S; Schmidt, W; Trummer, D | 1 |
| Imada, K; Mizuguchi, K; Nagaoka, T; Sasagawa, S; Shimizu, Y; Tokado, H | 1 |
| Imada, K; Mizuguchi, K; Sasagawa, S; Shimizu, Y | 1 |
| Gräser, T; Palombo-Kinne, E; Schellschmidt, I; Schumacher, U | 1 |
| Chaki, SP; Kaushik, MC; Misro, MM; Nandan, D | 1 |
| Inoue, M; Kiyono, T; Kyo, S; Mita, S; Mizuguchi, K; Shimizu, Y; Takeuchi, T | 1 |
| Blode, H; Lu, M; Morrison, D; Uddin, A; Zeiler, B; Zeun, S | 1 |
| Bühling, KJ; Mueck, AO; Seeger, H | 1 |
| Hoy, SM; Scott, LJ | 1 |
| Faustmann, TA; Gerlinger, C; Köhler, G; Mueck, AO; Seitz, C | 1 |
| Bitzer, J; Machlitt, A; Palacios, S; Parke, S; Römer, T; Wildt, L | 1 |
| Harada, T; Taniguchi, F | 1 |
| Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Palombo-Kinne, E; Sänger, N; Stahlberg, S; Wiegratz, I | 3 |
| Henkel, A; Moore, C; Oettel, M; Schindler, AE | 1 |
| Kitawaki, J | 1 |
| Faustmann, T; Gerlinger, C; Marr, J; Seitz, C; Strowitzki, T | 2 |
| Alsina, JC | 1 |
| Pérez-Campos, EF | 1 |
| Faustmann, T; Gerlinger, C; Seitz, C; Strowitzki, T | 1 |
| Assmann, A; Dinger, J; Minh, TD; Möhner, S | 1 |
| Hiratsuka, M; Ito, M; Katayama, H; Katayama, T; Kiyomura, M; Shimizu, Y; Sugita, A; Uematsu, K | 1 |
| Kyo, S; Mita, S; Mizuguchi, K; Notsu, T; Shimizu, Y; Takeuchi, T | 1 |
| Iwen, A; Lehnert, H | 1 |
| McCormack, PL | 1 |
| Ichigo, S; Imai, A; Matsunami, K; Suzuki, N; Takagi, H | 1 |
| Harada, M; Hirata, T; Izumi, G; Koga, K; Osuga, Y; Takamura, M; Takemura, Y; Taketani, Y; Yano, T; Yoshino, O | 1 |
| Keder, LM | 1 |
| Drife, JO | 1 |
| Fraser, IS; Jensen, JT; Machlitt, A; Mellinger, U; Parke, S | 1 |
| Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K | 1 |
| Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M | 1 |
| Faustmann, T; Gerlinger, C; Hornung, D; Lazzeri, L; Luisi, S; Petraglia, F; Seitz, C; Strowitzki, T | 1 |
| Fraser, IS; Jensen, J; Machlitt, A; Mellinger, U; Parke, S; Serrani, M | 1 |
| Fraser, IS; Jensen, JT; Machlitt, A; Mellinger, U; Parke, S; Römer, T; Zeun, S | 1 |
| Ichigo, S; Imai, A; Matsunami, K; Takagi, H | 1 |
| Jensen, JT; Micks, E | 1 |
| Fischer, OM; Fuhrmann, U; Kaufmann-Reiche, U; Moeller, C | 1 |
| Imada, K; Kyo, S; Mita, S; Notsu, T; Shimizu, Y | 1 |
| Ghosh, D; Meena, R; Misro, MM; Nandan, D | 2 |
| Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA | 1 |
| Duijkers, I; Faustmann, T; Klein, S; Klipping, C; Remmers, A; Schuett, B; Zurth, C | 1 |
| Kitawaki, J; Kusuki, I; Mita, S; Mizuguchi, K; Shimizu, Y; Suganuma, I; Xu, B; Yamanaka, K | 1 |
| Nappi, RE | 1 |
| Mueck, AO; Ruan, X; Seeger, H | 1 |
| Aoki, D; Banno, K; Kisu, I; Kobayashi, Y; Masuda, K; Nomura, H; Susumu, N; Tsuji, K; Ueki, A; Yamagami, W; Yanokura, M | 1 |
| Morikawa, A; Nagata, C; Ochiai, K; Okamoto, A; Okamoto, S; Sugimoto, K; Tanaka, T; Yanagida, S | 1 |
| Bitzer, J; Fruzzetti, F; Trémollieres, F | 1 |
| Faustmann, T; Gerlinger, C; Hassall, JJ; Seitz, C | 1 |
| Beranič, N; Rižner, TL | 1 |
| Duijkers, I; Endrikat, J; Klipping, C; Parke, S; Serrani, M; Trummer, D | 1 |
| Chaya, J; Hayashi, K; Kato, N; Nishino, K; Yamamuro, O | 1 |
| Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H | 1 |
| Beranič, N; Lanišnik Rižner, T | 1 |
| Ghosh, D; Meena, R; Misro, MM | 1 |
| Jang, IJ; Lee, S; Lim, KS; Park, JS; Shin, D; Shin, SG; Yu, KS | 1 |
| Ballieux, B; Helmerhorst, F; Raps, M; Rosendaal, F; Rosing, J; Thomassen, S; van Vliet, H | 1 |
| Martini, E; Nappi, RE; Sances, G; Santamaria, V; Spinillo, A; Tassorelli, C; Terreno, E; Tonani, S | 1 |
| Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Svelato, A; Tonni, G | 1 |
| De Leo, V; Di Sabatino, A; Fruzzetti, F; Morgante, G; Musacchio, MC; Scolaro, V | 1 |
| Bifulco, G; Di Carlo, C; Gargano, V; Nappi, C; Schettino, D; Sparice, S; Tommaselli, GA | 1 |
| Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M | 1 |
| Bifulco, G; Di Carlo, C; Gargano, V; Nappi, C; Sparice, S; Tommaselli, GA | 1 |
| Bitzer, J; Davis, SR; Giraldi, A; Mellinger, U; Nappi, RE; Palacios, S; Parke, S; Serrani, M | 1 |
| Akita, M; Brosens, JJ; Fujita, K; Ishihara, O; Kajihara, T; Matsumoto, S; Nagashima, M; Prechapanich, J; Sato, K; Tanaka, K; Uchino, S | 1 |
| Imada, K; Kyo, S; Mita, S; Notsu, T; Sato, A; Shimizu, Y | 1 |
| Schindler, AE | 1 |
| Avraham, S; Seidman, DS | 1 |
| Fukaya, T; Izumiya, C; Maeda, N; Matsushima, S; Mita, S; Shimizu, Y; Taniguchi, K | 1 |
| Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Miyashita, M; Nagai, M; Osuga, Y; Takamura, M | 1 |
| Iwasaki, M; Matsuura, M; Saito, T; Tabuchi, Y; Takada, S; Tamate, M; Tanaka, R | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
| Batta, N; Pallapothu, LM; Pigili, RK; Yejella, RP | 1 |
| Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Nakazawa, A; Osuga, Y; Saito, A; Takamura, M | 1 |
| Cagnacci, A; Grandi, G; Piacenti, I; Volpe, A | 1 |
| Kimura, F; Kishi, Y; Murakami, T; Shimizu, Y; Suginami, H; Takahashi, K; Yamanaka, A | 1 |
| Kurabayashi, T; Tamura, M; Tsuneki, I; Yanase, T | 1 |
| Bizzarri, N; Candiani, M; Ferrero, S; Ghirardi, V; Leone Roberti Maggiore, U; Remorgida, V; Salvatore, S; Scala, C; Tafi, E; Venturini, PL | 1 |
| Guvenal, T; Hasdemir, PS; Ikiz, N; Kara, E; Ozcakir, HT | 1 |
| Ferrero, S; Leone Roberti Maggiore, U; Salvatore, S | 1 |
| Hayashi, A; Hayashi, M; Kyo, S; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Yamashita, Y | 1 |
| Agarwal, S; Chen, I; Fraser, MA; Singh, SS | 1 |
| De Rosa, N; Di Carlo, C; Gargano, V; Nappi, C; Sparice, S; Tommaselli, GA | 1 |
| Fukuda, S; Hattori, K; Orisaka, M; Tsang, BK; Tsuyoshi, H; Yoshida, Y | 1 |
| Ferrero, S; Morotti, M; Remorgida, V; Sozzi, F; Venturini, PL | 1 |
| Bono, Y; Ichioka, M; Imada, K; Kiyono, T; Kyo, S; Mita, S; Shimizu, Y | 1 |
| Andres, Mde P; Baracat, EC; Lopes, LA; Podgaec, S | 1 |
| Ito, F; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Takaoka, O; Tanaka, Y | 1 |
| Angioni, S; Luisi, S; Mais, V; Melis, GB; Nappi, L; Pontis, A; Sedda, F | 1 |
| Hatano, K; Hiraku, Y; Morishige, K; Sato, K; Shibata, M; Takenaka, M; Yamamoto, K; Yamamoto, S; Yano, R | 1 |
| Fawzy, M; Mesbah, Y | 1 |
| Choi, D; Choi, J; Jo, M; Lee, DY; Lee, E | 2 |
| Bizzarri, N; Ferrero, S; Remorgida, V; Venturini, PL | 1 |
| Ishida, M; Kurabayashi, T; Morikawa, K; Nishijima, S; Takaki, Y; Tamura, M; Tsuneki, I; Yanase, T; Yokoo, T | 1 |
| Caruso, S; Casella, E; Cianci, A; Cianci, S; Fava, V; Iraci, M | 2 |
| Hayashi, H; Nagata, C; Okamoto, A; Sugimoto, K; Yanagida, S | 1 |
| Nelson, AL | 1 |
| Bersinger, NA; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Volpe, A | 1 |
| Alberico, D; Bracco, B; Dhouha, D; Mosconi, P; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Honda, R; Katabuchi, H; Ohba, T; Saito, F; Suzuki, A; Tashiro, H; Yamaguchi, M | 1 |
| Ban Frangež, H; Giacobbe, V; Granese, R; Ietto, C; Laganà, AS; Palmara, VI; Triolo, O; Vrtačnik-Bokal, E | 1 |
| Adachi, K; Fujitani, M; Kimura, T; Kobayashi, E; Miyoshi, Y; Nakamura, K; Otake, A; Sasamoto, N; Sawada, K; Shioji, M; Takahashi, K; Tokuhira, A; Wakimoto, A; Yamamoto, Y; Yoshimura, A | 1 |
| Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Cagnacci, A; Grandi, G; Napolitano, A | 1 |
| de la Viuda, E; Lete, I; Martínez, MÁ; Novalbos, J; Pérez-Campos, E; Sánchez-Borrego, R; Sanchez-de la Rosa, R | 1 |
| Isaka, K; Kato, R; Kojima, J; Nagamitsu, Y; Nishi, H; Sasaki, T; Takaesu, Y | 1 |
| Ani Amelia, Z; Chew, KT; Hing, EY; Nor Azlin, MI; Norsaadah, S; Nur Azurah, AG; Suraya, A | 1 |
| Dinger, J; Do Minh, T; Heinemann, K | 1 |
| Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K | 1 |
| Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A | 1 |
| Choi, D; Lee, DY; Lee, JY; Seo, JW; Yoon, BK | 1 |
| Fujii, T; Harada, M; Hirata, T; Hirota, Y; Koga, K; Makabe, T; Miyashita, M; Osuga, Y; Sue, F; Takeuchi, A | 1 |
| Buscema, M; Frangež, HB; Giunta, L; Granese, R; Laganà, AS; Muscia, V; Palmara, V; Rapisarda, AM; Romano, A; Rossetti, P; Triolo, O; Vitale, SG | 1 |
| Alfaraj, S; Allaire, C; Bedaiwy, MA | 1 |
| Casper, RF | 1 |
| Böttcher, B; Dong, L; Ebert, AD; Francuski, M; Gude, K; Hlavackova, O; Kirsch, B; Merz, M; Roman, H; Seitz, C; Suvitie, P | 1 |
| Benetti-Pinto, CL; Cursino, K; Leonardo-Pinto, JP; Yela, DA | 1 |
| Choi, D; Lee, DY; Seo, JW; Yoon, BK | 1 |
| Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD | 1 |
| Baldane, S; Celik, C; Dursunoglu, D; Ilhan, TT; Ipekci, SH; Kebapcilar, AG; Kebapcilar, L; Kirac, CO; Kurt, K; Ucar, MG | 1 |
| Hashiba, M; Ichioka, M; Kyo, S; Mita, S; Miyazaki, H; Nakakuki, M; Shimizu, Y | 1 |
| Ban Frangež, H; Chiofalo, B; Granese, R; Laganà, AS; Palmara, V; Triolo, O; Vitale, SG; Vrtačnik-Bokal, E | 1 |
| Black, A; Chen, I; Hodge, MC; Lalani, S; Tulandi, T | 1 |
| Alio, L; Alio, W; Giambanco, L; Incandela, D; Maiorana, A; Mercurio, A; Parazzini, F | 1 |
| Acmaz, G; Akkaya, H; Cagli, F; Karakilic, EU; Madendag, I; Madendag, Y; Uysal, G | 1 |
| Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S | 1 |
| Hagino, A; Osuga, Y; Watanabe, M | 1 |
| Fujimoto-Okabe, H; Hagino, A; Osuga, Y | 1 |
| Berg, SM; Cwiertny, DM; Gloer, JB; Hankard, MK; Kolodziej, EP; O'Connor, M; Pflug, NC; Wammer, KH | 1 |
| Dong, L; Gude, K; Lang, J; Li, H; Ren, X; von Ludwig, C; Yu, Q; Zhang, S | 1 |
| Arena, A; Caprara, G; Del Forno, S; Mabrouk, M; Matteucci, C; Paradisi, R; Seracchioli, R; Zannoni, L | 1 |
| Cho, S; Kim, SH; Lee, DY; Lee, SR; Seo, SK; Song, JY; Yi, KW | 1 |
| Aylamazyan, E; Gzgzyan, A; Kogan, I; Muller, V; Niauri, D; Yarmolinskaya, M | 1 |
| Kamada, Y; Kotani, S; Masuyama, H; Sakamoto, A | 1 |
| Chabbert-Buffet, N; Fernandez, H; Geoffron, S; Legendre, G; Sauvan, M; Wattier, JM | 1 |
| Bouet, PE; Chabbert-Buffet, N; Delbos, L; Descamps, P; Fernandez, H; Geoffron, S; Hudon, E; Legendre, G; Sauvan, M | 1 |
| Kimura, F; Mita, S; Morimune, A; Murakami, T; Niwa, Y; Takahashi, K; Wu, D; Zheng, L | 1 |
| Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H | 1 |
| Caserta, D; Maniglio, P; Meli, F; Peiretti, M; Ricciardi, E; Tomao, F | 1 |
| Jee, BC; Jeong, SH; Kim, SK; Lee, D | 1 |
| Angerame Yela, D; Laguna Benetti-Pinto, C; Paulo Leonardo-Pinto, J | 1 |
| Fujii, T; Fukuda, S; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Nakazawa, A; Neriishi, K; Osuga, Y; Wada-Hiraike, O; Yamamoto, N | 1 |
| Cho, S; Kim, SH; Lee, DY; Lee, JH; Lee, SR; Seo, SK; Shin, JH; Song, JY; Yi, KW | 1 |
| Han, HY; Jung, YW; Kang, BH; Ko, YB; Lee, KH; Lee, M; Song, SY; Yang, JB; Yoo, HJ | 1 |
| Akiyama, K; Ito, F; Kataoka, H; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Okimura, H; Takaoka, O | 1 |
| Mizunuma, H; Ota, K; Shiraishi, S; Takahashi, T | 1 |
| Herrmann, J; Kochhar, PS; Markert, UR; Morales-Prieto, DM; Oettel, M; Osterwald, H; Schleussner, E | 1 |
| Beckmann, MW; Boosz, A; Dittrich, R; Hoffmann, I; Lotz, L; Mueller, A; Oppelt, PG; Raffel, N; Weber, M | 1 |
| Römer, T | 1 |
| Roth, K; Schäfer, WR; Zahradnik, HP | 1 |
| Hiramatsu, T; Hongo, K; Kazama, S; Kuriki, K; Kuroda, K; Tanaka, T; Watanabe, Y | 1 |
| Ziegler, C | 1 |
| Dong, L; Lang, J; Li, H; Ren, X; Wang, P; Yu, Q; Zhang, S; Zvolanek, M | 1 |
| Awaga, Y; Hama, A; Hayashi, I; Matsuda, A; Natsume, T; Ogawa, S; Takamatsu, H; Yano, M | 1 |
| Choi, D; Kim, SE; Lee, DY; Seo, JW; Yoon, BK | 1 |
| Cwiertny, DM; Gloer, JB; Knutson, CJ; Martinović-Weigelt, D; Pflug, NC; Swenson, DC; Wammer, KH | 1 |
| Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y | 1 |
| Dashraath, P; Kailun, C; Li, M | 1 |
| Ahlers, C; Banal-Silao, MJ; Hestiantoro, A; Kim, MR; Lee, BS; Ruey, S; Seong, SJ; Shin, SY; Techatraisak, K; Thaufik, S | 1 |
| Arena, A; Del Forno, S; Giaquinto, I; Mabrouk, M; Mattioli, G; Paradisi, R; Seracchioli, R | 1 |
| Angioni, S; Cela, V; Litta, P; Luisi, S; Malune, ME; Nappi, L; Pontis, A; Vignali, M | 1 |
| Arakawa, T; Fujii, T; Fukuda, S; Harada, M; Hirata, T; Hirota, Y; Koga, K; Ma, S; Nagashima, N; Neriishi, K; Osuga, Y; Sun, H; Wada-Hiraike, O | 1 |
| Bardhi, E; Boccia, SM; Musella, A; Palaia, I; Panici, PB; Pecorini, F | 1 |
| Fujimoto, A; Honda, M; Isono, W; Matsuyama, R; Nishii, O; Saito, A; Tsuchiya, A; Tsuchiya, H | 1 |
| Akira, S; Matsushima, T; Takeshita, T; Yoneyama, K | 1 |
| Hayashi, K; Kanda, S; Osuga, Y | 3 |
| Akinishi, M; Iwai, K; Kawaguchi, R; Kobayashi, H; Matsubara, S; Nagayasu, M; Niiro, E; Tanase, Y; Yamada, Y | 1 |
| Hudeček, R; Papíková, Z; Szypulová, M; Ventruba, P | 1 |
| Josaki, M; Kikuchi, H; Mihara, Y; Shinagawa, M; Shirafuta, Y; Sugino, N; Takasaki, A; Taketani, T; Tamura, H; Tamura, I; Yoshida, H | 1 |
| Fukui, Y; Hashimoto, T; Hayashi, T; Hirota, Y; Ikemura, M; Inoue, S; Kawazu, M; Kiyono, T; Kojima, S; Mano, H; Muraoka, A; Oda, K; Osuga, Y; Osuka, S; Saito, T; Sakata, S; Taguchi, A; Takeuchi, K; Takeyama, R; Tanaka, T; Tanaka, Y; Terao, Y; Ueno, T; Yoshida, E | 1 |
| Li, C; Li, F; Li, L; Li, N; Li, T; Xue, J | 1 |
| Yunker, AC | 1 |
| Cho, B; Cho, CH; Jeong, K; Kim, SH; Kim, TH; Kim, YS; Kwon, YS; Park, J; Park, SH; Roh, JW | 1 |
| Angioni, S; Barbasetti Di Prun, A; Barbera, V; Belloni, GM; Pietropaolo, G; Pino, I; Vignali, M | 1 |
| Biberoğlu, K; Leng, J; Mueller, MD; Murji, A; Römer, T; Vignali, M; Yarmolinskaya, M | 1 |
| Becker, K; Faustmann, T; Gerlinger, C; Heinemann, K; Imthurn, B; Marions, L; Moehner, S | 1 |
| Arffman, RK; Haverinen, A; Heikinheimo, O; Hiltunen, JK; Kangasniemi, MH; Komsi, EK; Luiro, K; Piltonen, TT; Tapanainen, JS | 1 |
| Abdelhakim, AM; Ahmed, SA; AlAmodi, AA; Ali, AS; Ashour, K; El Kattan, EAM; Elsherbini, M; Fathi, M; Haggag, H; Keshta, NHA; Salah, DM; Samy, A; Shareef, MA; Shatat, HBAE; Sileem, SA; Taher, A | 1 |
| Ikuma, S; Jinushi, M; Kawasaki, Y; Kitade, M; Kumakiri, J; Murakami, K; Ozaki, R | 1 |
| Nickisch, K; Oettel, M; Zentel, HJ | 1 |
| Agliati, L; Gasparri, ML; McKinnon, B; Mueller, MD; Nirgianakis, K; Vaineau, C | 1 |
| Barra, F; Ferrero, S; Garzon, S; Ghezzi, F; Laganà, AS; Scala, C | 1 |
| Ainsworth, AJ; Cope, AG; Stewart, EA | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Iwami, N; Kamiya, H; Kawamata, M; Mizuuchi, M; Moriwaka, O; Ozawa, N; Watanabe, E; Yamamoto, T | 1 |
| Fukutomi, T; Kobayashi, Y; Mita, S; Suzuki, A; Watanabe, M | 1 |
| Choi, D; Kim, SE; Lee, DY; Lim, HH | 1 |
| Ali, MK; Hassanin, AI; Yousef, AM; Youssef, AA | 1 |
| Asano, R; Miyagi, E; Nagai, K; Nakamura, T; Ono, N; Sugo, Y | 1 |
| Aygen, EM; Demirtas, E; Sahin, Y; Uludag, SZ | 1 |
| Alkatout, I; Allahqoli, L; Ebrahimpour, M; Gitas, G; Hassanlouei, B; Mehdizadeh Kashi, A; Niakan, G | 1 |
| Abdel-Rasheed, M; Abdullah, A; Hosni, M; Khairy, M; Khalifa, E; Mohammad, H | 1 |
| Ceccarello, M; Ceccaroni, M; Clarizia, R; Donati, A; Ferrero, S; Liverani, S; Manzone, M; Roviglione, G | 1 |
| Fukami, T; Matsushima, T; Shinmura, H; Takeshita, T | 1 |
| Dai, Y; Duan, J; Ha, C; Huang, R; Huang, X; Liu, J; Qiu, Y; Shi, B; Xiao, D; Xuan, J | 1 |
| Kim, KE; Kolodziej, EP; Lam, K; Tian, Z; Wang, R; Zhao, HN | 1 |
| Lee, SM; Park, JK | 1 |
| Huang, Y; Ji, M; Jiao, X; Li, J; Li, Q; Wang, G; Yuan, M | 1 |
| Ebrahimpour, M; Mehdizadeh Kashi, A; Niakan, G; Rokhgireh, S | 1 |
| Abbasi, S; Abu Musa, A; El Taha, L; Khalifeh, D; Khalil, A; Nassif, J | 1 |
| Goto, M; Iwase, A; Kajiyama, H; Miyake, N; Murakami, M; Muraoka, A; Nakamura, T; Nakanishi, N; Osuka, S; Sonehara, R; Tanaka, H; Yabuki, A; Yoshihara, M; Yoshita, S | 1 |
| Banal-Silao, MJ; Cai, L; Hestiantoro, A; Hidayat, ST; Kim, MR; Lee, BS; Seong, SJ; Shin, S; Soon, R; Techatraisak, K | 1 |
| Engin-Ustun, Y; Ibanoglu, MC; Kıykac Altinbas, S; Kizilkaya, Y | 1 |
| Duffy, JMN; Farquhar, CM; Hirsch, M | 1 |
| Allahqoli, L; Ebrahimpour, M; Hassanlouei, B; Niakan, G | 1 |
| Caruso, G; Caruso, S; Cianci, A; Cianci, S; Iraci Sareri, M; Panella, M | 1 |
| Fukuda, H; Kubo, A; Kunisada, M; Yoshioka, A | 1 |
| Choi, D; Choi, SH; Kim, SE; Lee, DY; Lim, HH | 1 |
| Lu, J; Lu, P; Miao, J; Tang, J | 1 |
| Chen, LH; Feng, M; Hsu, LT; Wu, HM | 1 |
| Li, Z; Wang, L; Wang, X; Zhang, Z | 1 |
| Kadirogullari, P; Seckin, KD | 1 |
| Alfano, P; Audino, P; Incandela, D; Maiorana, A; Marcantonio, S; Mercurio, A; Minneci, G | 1 |
| Li, X; Lin, J; Liu, Y; Zhang, L | 1 |
| Akimoto, Y; Honda, H; Kaneko, M; Nishimichi, N; Tanimoto, H; Teramoto, H; Teramoto, M; Yamashita, M; Yokosaki, Y | 1 |
| Bitoh, Y; Iwabuchi, S; Okata, Y; Samejima, Y; Tomioka, Y; Uemura, K; Watanabe, A; Yoshimura, S | 1 |
| Tang, M; Yang, W; Zhang, H | 1 |
| Hosseini, L; Hosseini, R; Rastad, H; Rodi, H; Vahid-Dastjerdi, M | 1 |
| Abdeldayem, HM; Girbash, EF; Radwan, AM; Sherif, HE | 1 |
| Dietrich, H; Imesch, P; Knobel, C; Merki-Feld, GS; Metzler, J; Muendane, A; Neumeier, MS; Niggli, A; Portmann, L | 1 |
| Bogani, G; Carbone, F; Di Donato, V; Di Tucci, C; Galati, G; Kontopantelis, E; Muzii, L; Palaia, I; Perniola, G; Tomao, F | 1 |
| Arena, A; Aru, AC; Borghese, G; Caroli, M; Casadio, P; Del Forno, S; Lenzi, J; Meriggiola, MC; Orsini, B; Paradisi, R; Raimondo, D; Seracchioli, R; Verrelli, L | 1 |
| Guo, W; Hu, S; Lin, Y; Shen, Y | 1 |
48 review(s) available for nandrolone and dienogest
| Article | Year |
|---|---|
[New progestational hormones].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners | 1988 |
Dienogest.
Topics: Androgen Antagonists; Animals; Clinical Trials as Topic; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Nandrolone; Progestins | 1998 |
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
The role of antiandrogens in hormone replacement therapy.
Topics: Androgen Antagonists; Biological Availability; Body Weight; Chemistry, Pharmaceutical; Cognition; Coronary Disease; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Osteoporosis, Postmenopausal; Patient Selection; Progesterone Congeners; Treatment Outcome | 2000 |
[What is the role of hormonal treatments in acne?].
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Estrogens; Flutamide; Glucocorticoids; Hormone Antagonists; Humans; Mineralocorticoid Receptor Antagonists; Nandrolone; Patient Selection; Progestins; Spironolactone; Treatment Outcome | 2001 |
Progestogens with antiandrogenic properties.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Animals; Chlormadinone Acetate; Clinical Trials as Topic; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Dermatitis, Seborrheic; Female; Hirsutism; Humans; Nandrolone; Progesterone Congeners; Progestins; Receptors, Androgen | 2003 |
Use of progestins in male contraception.
Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People | 2003 |
Alternatives for optimal hormone replacement therapy.
Topics: Chemistry, Pharmaceutical; Drug Delivery Systems; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Quality of Life; Women's Health | 2003 |
Pharmacology of estradiol valerate/dienogest.
Topics: Drug Administration Schedule; Drug Combinations; Endometrium; Estradiol; Female; Humans; Nandrolone | 2003 |
Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
Topics: Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Nandrolone; Uterine Hemorrhage | 2003 |
[Pharmacological and clinical profile of dienogest (DINAGEST Tab. 1 mg)].
Topics: Animals; Endometriosis; Female; Hormone Antagonists; Humans; Macaca mulatta; Mice; Nandrolone; Progesterone Congeners; Rabbits; Uterine Diseases | 2009 |
Estradiol valerate/dienogest: in oral contraception.
Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Contraceptives, Oral; Drug Combinations; Estradiol; Female; Humans; Middle Aged; Nandrolone; Pregnancy; Young Adult | 2009 |
Dienogest: a new therapeutic agent for the treatment of endometriosis.
Topics: Animals; Dysmenorrhea; Endometriosis; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovary; Rabbits; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Hemorrhage | 2010 |
[Maintenance therapy for endometriosis].
Topics: Clinical Trials as Topic; Contraceptives, Oral; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Progesterone Congeners | 2010 |
Ethinylestradiol/dienogest in oral contraception.
Topics: Animals; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Nandrolone | 2010 |
Estradiol + dienogest. Oral contraception: estradiol does not provide a therapeutic advantage.
Topics: Contraceptives, Oral, Sequential; Drug Interactions; Estradiol; Female; Humans; Nandrolone | 2010 |
What role for Qlaira in contraception?
Topics: Adolescent; Adult; Contraceptives, Oral, Sequential; Drug Costs; Drug Interactions; Estradiol; Female; Humans; Middle Aged; Nandrolone; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Young Adult | 2010 |
Dienogest: a review of its use in the treatment of endometriosis.
Topics: Animals; Endometriosis; Female; Humans; Nandrolone; Progestins | 2010 |
A new estradiol-dienogest oral contraceptive marks "The Pill's" 50th anniversary.
Topics: Adult; Chemistry, Pharmaceutical; Contraceptives, Oral, Hormonal; Drug Approval; Estradiol; Estrogens; Female; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Nandrolone; Progestins; United States; United States Food and Drug Administration | 2011 |
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Topics: Adult; Contraceptives, Oral; Drug Combinations; Estradiol; Female; Humans; Intention to Treat Analysis; Iron; Menorrhagia; Menstrual Hygiene Products; Middle Aged; Nandrolone; Randomized Controlled Trials as Topic | 2011 |
Quadriphasic versus monophasic oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
[Association of E2v/DNG as contraceptive choice for a better quality of life of women].
Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Nandrolone; Quality of Life; Sexuality | 2012 |
The pharmacology of dienogest.
Topics: Contraceptives, Oral; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Progestins | 2012 |
Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
Topics: Animals; Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Nandrolone; Progestins | 2012 |
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest.
Topics: Contraceptives, Oral, Combined; Estradiol; Female; History, 20th Century; Humans; Nandrolone | 2012 |
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
Topics: Asian People; Buserelin; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Japan; Leuprolide; Nandrolone; Treatment Outcome; White People | 2012 |
The "newer" progestogens and postmenopausal hormone therapy (HRT).
Topics: Androstenes; Estradiol; Female; Humans; Megestrol; Nandrolone; Norpregnadienes; Postmenopause; Progestins | 2014 |
Dienogest in the treatment of endometriosis.
Topics: Administration, Oral; Clinical Trials as Topic; Endometriosis; Female; Humans; Nandrolone; Progestins | 2014 |
Dienogest for the treatment of deep endometriosis: case report and literature review.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Urinary Bladder Diseases; Vaginal Diseases | 2015 |
Dienogest in the treatment of endometriosis: systematic review.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Progestins; Treatment Outcome | 2015 |
Endometriosis: the effects of dienogest.
Topics: Endometriosis; Female; Humans; Nandrolone | 2015 |
An update on new orally administered contraceptives for women.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Nandrolone; Norpregnadienes; Progestins | 2015 |
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.
Topics: Animals; Cytokines; Endometriosis; Epithelial Cells; Female; Hormone Antagonists; Humans; Immunologic Factors; Intercellular Signaling Peptides and Proteins; Nandrolone; Prostaglandins; Stromal Cells | 2016 |
Metabolic impact of combined hormonal contraceptives containing estradiol.
Topics: Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Hemostasis; Humans; Lipid Metabolism; Megestrol; Nandrolone; Norpregnadienes | 2016 |
Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review.
Topics: Endometrium; Female; Humans; Hysteroscopy; Nandrolone | 2017 |
Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
Topics: Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Medication Adherence; Nandrolone; Pelvic Pain; Progestins; Recurrence; Treatment Outcome; Young Adult | 2017 |
Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.
Topics: Administration, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Treatment Outcome | 2017 |
Dienogest Therapy as a Treatment for Catamenial Pneumothorax: Case Report and Review of Hormonal Options.
Topics: Adult; Female; Hormone Antagonists; Humans; Leuprolide; Nandrolone; Pneumothorax | 2017 |
[Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines].
Topics: Adolescent; Contraceptives, Oral; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Pelvic Pain | 2018 |
[New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
Topics: Aromatase Inhibitors; Contraceptives, Oral; Dyspareunia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone; Pelvic Pain; Selective Estrogen Receptor Modulators | 2018 |
Use of dienogest in endometriosis: a narrative literature review and expert commentary.
Topics: Bone Density; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone | 2020 |
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
Topics: Contraceptive Agents, Hormonal; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Levonorgestrel; Nandrolone; Network Meta-Analysis; Pelvic Pain; Pyrimidines; Randomized Controlled Trials as Topic; Visual Analog Scale | 2021 |
A progestin isn't a progestin: dienogest for endometriosis as a blueprint for future research - Review as a contribution for discussion.
Topics: Clinical Decision-Making; Contraceptives, Oral, Hormonal; Disease Management; Endometriosis; Female; Humans; Nandrolone; Progestins; Structure-Activity Relationship; Treatment Outcome | 2020 |
Current and Future Medical Therapies for Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hormone Antagonists; Humans; Levonorgestrel; Menorrhagia; Nandrolone; Pain Measurement; Quality of Life | 2020 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
Segmented in vitro fertilization and frozen embryo transfer in dienogest-treated patient with adenomyosis: A case report and lierature review.
Topics: Adenomyosis; Adult; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone; Pregnancy | 2022 |
Pretreatment of Dienogest for Women with Endometriosis in in vitro Fertilization: A Systematic Review and Meta-Analysis.
Topics: Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Ovulation Induction; Pregnancy; Pregnancy Rate | 2023 |
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis.
Topics: Cysts; Endometriosis; Female; Hot Flashes; Humans; Nandrolone; Pelvic Pain; Progestins | 2023 |
93 trial(s) available for nandrolone and dienogest
| Article | Year |
|---|---|
[Steroid receptors in the gestagen treatment of endometriosis].
Topics: Adult; Endometriosis; Female; Humans; Nandrolone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1990 |
[Postcoital contraception with dienogest].
Topics: Adult; Clinical Trials as Topic; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Female; Humans; Menstrual Cycle; Middle Aged; Nandrolone; Pregnancy | 1987 |
Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral; Double-Blind Method; Ethinyl Estradiol; Factor VII; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Nandrolone; Peptide Fragments; Placebos; Plasminogen; Protein C; Prothrombin; Tissue Plasminogen Activator | 1997 |
Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
Topics: Adult; Contraceptives, Oral; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovarian Follicle; Ovulation; Progesterone; Ultrasonography | 1997 |
[Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Nandrolone; Sex Hormone-Binding Globulin | 1997 |
Influence of hormonal contraceptives on microbial flora of gingival sulcus.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gingiva; Humans; Nandrolone; Porphyromonas gingivalis; Prevotella intermedia | 1998 |
A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system.
Topics: Adolescent; Adult; CD4 Lymphocyte Count; Contraceptives, Oral; Desogestrel; Female; Humans; Immunity; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Interleukin-6; Leukocyte Count; Menstrual Cycle; Nandrolone | 2000 |
Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Germany; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Nandrolone; Progesterone Congeners | 2000 |
Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH).
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levonorgestrel; Linear Models; Nandrolone; Time Factors | 2000 |
Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
Topics: Affect; Arousal; Cognition; Double-Blind Method; Drug Combinations; Electroencephalography; Estradiol; Estrogens; Evoked Potentials; Female; Humans; Menopause; Middle Aged; Nandrolone; Personality; Progestins; Psychometrics; Psychomotor Performance; Pupil; Sleep | 2001 |
Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest.
Topics: Administration, Oral; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Diseases; Cyclic GMP; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Peptide Fragments; Postmenopause; Prospective Studies; Serotonin; Vasodilation | 2001 |
[Treatment of endometriosis with dienogest: preliminary report].
Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Nandrolone; Pelvic Inflammatory Disease; Severity of Illness Index; Treatment Outcome | 2001 |
Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
Topics: Aged; Bone Resorption; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estradiol; Europe; Female; Follicle Stimulating Hormone; Hormone Replacement Therapy; Hot Flashes; Humans; Lipoproteins; Middle Aged; Nandrolone; Patient Satisfaction; Postmenopause; Triglycerides; Ultrasonography; Uterine Hemorrhage | 2001 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |
Effect of dienogest-containing oral contraceptives on lipid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Nandrolone; Statistics, Nonparametric | 2002 |
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
Topics: Adolescent; Adult; Alkaline Phosphatase; Cholesterol; Cholesterol, HDL; Combined Modality Therapy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Triptorelin Pamoate | 2002 |
Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men.
Topics: Adult; Contraceptive Agents, Male; Drug Administration Schedule; Gonadotropins; Hormones; Humans; Male; Nandrolone; Penile Erection; Reference Values; Spermatogenesis; Testosterone | 2002 |
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
Topics: Aged; Arousal; Brain Mapping; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Postmenopause; Sleep Wake Disorders; Syndrome; Treatment Outcome | 2002 |
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
Topics: Adolescent; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Nandrolone; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins; Treatment Outcome | 2003 |
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
Topics: Affect; Aged; Double-Blind Method; Drug Combinations; Electrophysiology; Estradiol; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Neuropsychological Tests; Postmenopause; Progesterone Congeners; Reaction Time; Sleep Initiation and Maintenance Disorders | 2003 |
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hair; Humans; Nandrolone; Prospective Studies; Skin | 2002 |
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Contraceptives, Oral, Combined; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone; Thyroid Hormones; Treatment Outcome | 2003 |
Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Topics: Aged; Arousal; Cognition; Drug Therapy, Combination; Electrocardiography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Postmenopause; Sleep Wake Disorders; Surveys and Questionnaires; Treatment Outcome | 2003 |
[Influence of a new monophasic oral contraceptive on body metabolism].
Topics: Adolescent; Adult; Basal Metabolism; Cohort Studies; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Nandrolone; Time Factors; Treatment Outcome | 2003 |
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
Topics: Breast; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Substances; Hormones; Humans; Mammography; Nandrolone; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Testosterone | 2004 |
Effect of four oral contraceptives on hemostatic parameters.
Topics: alpha-2-Antiplasmin; Antithrombins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estradiol; Ethinyl Estradiol; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Nandrolone; Peptide Fragments; Plasminogen; Plasminogen Inactivators; Protein C; Prothrombin; Tissue Plasminogen Activator | 2004 |
Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.
Topics: Depression; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome | 2004 |
Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women.
Topics: C-Reactive Protein; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Glycine max; Humans; Isoflavones; Lipoproteins; Middle Aged; Nandrolone; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Treatment Outcome | 2005 |
The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Topics: Adult; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Nandrolone; Postmenopause; Treatment Outcome | 2005 |
Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest.
Topics: Adult; Age Distribution; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Fertility; Germany; Humans; Nandrolone; Outcome Assessment, Health Care; Pregnancy; Pregnancy Rate; Risk Assessment; Risk Factors; Treatment Outcome; Withholding Treatment | 2006 |
Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
Topics: Arousal; Coitus; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hormone Antagonists; Humans; Libido; Middle Aged; Nandrolone; Norpregnenes; Patient Satisfaction; Postmenopause; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Single-Blind Method; Treatment Outcome | 2006 |
A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women
Topics: Aged; Bulgaria; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Germany; Hemostasis; Humans; Hungary; Lipids; Middle Aged; Nandrolone; Poland; Postmenopause | 2007 |
A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Germany; Hot Flashes; Humans; Middle Aged; Nandrolone; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Nandrolone; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroid Hormones; Thyroxine-Binding Proteins | 2008 |
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies | 2008 |
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
Topics: Abdominal Pain; Administration, Intranasal; Administration, Oral; Bone Density; Buserelin; Double-Blind Method; Dyspareunia; Endometriosis; Female; Humans; Japan; Low Back Pain; Nandrolone; Pain; Pain Measurement; Treatment Outcome | 2009 |
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Female; Humans; Nandrolone; Ovulation Inhibition; Young Adult | 2008 |
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Germany; Hemostasis; Humans; Nandrolone; Prospective Studies | 2008 |
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Nandrolone; Young Adult | 2009 |
Dienogest and the breast.
Topics: Adult; Breast; Endometriosis; Female; Fibrocystic Breast Disease; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Ultrasonography, Mammary; Young Adult | 2009 |
Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Headache; Humans; Middle Aged; Nandrolone; Radioimmunoassay; Sex Hormone-Binding Globulin; Young Adult | 2009 |
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.
Topics: Adult; Dose-Response Relationship, Drug; Endometriosis; Female; Fertility; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
Topics: Adolescent; Adult; Austria; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Female; Germany; Humans; Middle Aged; Nandrolone; Patient Compliance; Patient Satisfaction; Spain; Surveys and Questionnaires; Treatment Outcome | 2010 |
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Intention to Treat Analysis; Lipid Metabolism; Nandrolone; Patient Selection; Triglycerides | 2010 |
Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis.
Topics: Adolescent; Adult; Antithrombin III; Cholesterol; Dose-Response Relationship, Drug; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Peptide Fragments; Pilot Projects; Protein C; Prothrombin; Surveys and Questionnaires; Young Adult | 2010 |
Long-term use of dienogest for the treatment of endometriosis.
Topics: Adult; Bone Density; Endometriosis; Female; Hormone Antagonists; Humans; Longitudinal Studies; Middle Aged; Nandrolone; Prospective Studies; Young Adult | 2009 |
Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
Topics: Adult; Bone Density; Endometriosis; Female; Humans; Leuprolide; Nandrolone; Pelvic Pain; Progestins; Quality of Life | 2010 |
Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Menstruation; Nandrolone; Prospective Studies; Young Adult | 2010 |
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Double-Blind Method; Endometriosis; Europe; Female; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Progesterone Congeners; Quality of Life; Surveys and Questionnaires; Young Adult | 2010 |
Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
Topics: Adult; Confidence Intervals; Contraceptives, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Humans; Menorrhagia; Nandrolone; Patient Satisfaction; Quality of Life; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2011 |
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2011 |
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult | 2011 |
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment.
Topics: Adolescent; Adult; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Germany; Hormone Antagonists; Humans; Italy; Middle Aged; Nandrolone; Pelvic Pain; Ukraine; Young Adult | 2012 |
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
Topics: Adult; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Nandrolone; Patient Satisfaction; Prospective Studies; Young Adult | 2011 |
Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
Topics: Adult; Australia; Contraceptive Agents; Contraceptives, Oral; Double-Blind Method; Estradiol; Europe; Female; Humans; Menorrhagia; Menstruation; Menstruation Disturbances; Nandrolone; Placebos; Treatment Outcome | 2011 |
Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women.
Topics: Adolescent; Adult; Contraceptives, Oral; Double-Blind Method; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovarian Follicle; Ovulation; Young Adult | 2012 |
Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Dysmenorrhea; Endometriosis; Estrogens; Female; Humans; Leuprolide; Middle Aged; Nandrolone; Pelvic Pain; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult | 2012 |
Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptives, Oral, Combined; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovary; Ovulation; Pituitary Gland; Progesterone | 2013 |
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Nandrolone; Sex Hormone-Binding Globulin; Young Adult | 2013 |
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?
Topics: Adolescent; Adult; Combined Modality Therapy; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laparoscopy; Nandrolone; Norpregnenes; Ovarian Diseases; Secondary Prevention; Treatment Outcome; Young Adult | 2013 |
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult | 2013 |
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Substitution; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Sexual Dysfunction, Physiological; Young Adult | 2013 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
Topics: Adult; Contraceptives, Oral; Endometriosis; Female; Follow-Up Studies; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Rectal Diseases; Treatment Outcome; Vaginal Diseases | 2014 |
Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
Topics: Adult; Danazol; Female; Hormone Antagonists; Humans; Hysteroscopy; Leiomyoma; Nandrolone; Preoperative Care; Preoperative Period; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2016 |
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone | 2016 |
Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study).
Topics: Adolescent; Adult; Condoms; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Megestrol; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Premenstrual Syndrome; Prospective Studies; Quality of Life; Young Adult | 2016 |
Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
Topics: Adult; Conservative Treatment; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormone Antagonists; Humans; Nandrolone; Pain; Postoperative Care; Prospective Studies; Recurrence; Secondary Prevention | 2016 |
The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.
Topics: Adult; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Premenopause; Progesterone; Progestins; Prospective Studies | 2018 |
Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.
Topics: Adenomyosis; Adult; Double-Blind Method; Female; Humans; Japan; Menstruation Disturbances; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Placebos; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study.
Topics: Adolescent; Adult; Asian People; Bone Density; China; Double-Blind Method; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Progestins; Treatment Outcome; Young Adult | 2018 |
Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
Topics: Adult; Endometriosis; Endometrium; Female; Humans; Inflammation; Middle Aged; Nandrolone; Ovarian Diseases; Prospective Studies; Treatment Outcome; Young Adult | 2018 |
Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases.
Topics: Cell Line; Cell Proliferation; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Humans; Indoles; Nandrolone | 2018 |
Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study.
Topics: Asian People; Bone Density; China; Double-Blind Method; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Treatment Outcome | 2019 |
Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Dysmenorrhea; Female; Hemorrhage; Hormone Antagonists; Humans; Nandrolone; Treatment Outcome | 2020 |
The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis.
Topics: Adult; Cytokines; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Oxidative Stress; Treatment Outcome | 2019 |
Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea.
Topics: Adult; Drug Administration Schedule; Dysmenorrhea; Female; Hormone Antagonists; Humans; Menstruation Disturbances; Nandrolone; Severity of Illness Index; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2020 |
Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pain; Prospective Studies; Treatment Outcome | 2020 |
A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea.
Topics: Administration, Oral; Adult; Back Pain; Dosage Forms; Double-Blind Method; Dysmenorrhea; Female; Humans; Japan; Nandrolone; Pain Measurement; Pelvic Pain; Placebos; Treatment Outcome; Young Adult | 2020 |
Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
Topics: Adult; C-Reactive Protein; Cholesterol; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Inflammation; Lipid Metabolism; Lipoproteins, LDL; Nandrolone; Serum Amyloid P-Component; Triglycerides; Young Adult | 2020 |
Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial.
Topics: Adenomyosis; Adult; Contraceptives, Oral, Combined; Egypt; Female; Humans; Nandrolone; Pain Measurement; Uterine Hemorrhage | 2021 |
A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.
Topics: Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Nandrolone; Pilot Projects; Quality of Life | 2022 |
Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial.
Topics: Adult; Embryo Transfer; Endometriosis; Female; Humans; Infertility, Female; Leuprolide; Nandrolone; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Treatment Outcome | 2021 |
Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intestines; Laparoscopy; Leuprolide; Nandrolone; Pelvic Pain; Peritoneum; Postoperative Care; Pregnancy; Recurrence; Reoperation; Secondary Prevention; Treatment Outcome; Triptorelin Pamoate | 2021 |
Comparing the Effect of Dienogest and OCPS on Pain and Quality of Life in Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Endometriosis; Female; Humans; Iran; Nandrolone; Pain Measurement; Pelvic Pain; Quality of Life; Treatment Outcome | 2021 |
Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial.
Topics: Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Quality of Life; Retrospective Studies | 2021 |
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.
Topics: Adult; Cystectomy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Reserve; Treatment Outcome; Urinary Bladder Diseases | 2021 |
Re: A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.
Topics: Contraceptives, Oral, Combined; Double-Blind Method; Endometriosis; Female; Humans; Nandrolone; Pilot Projects | 2022 |
Response: A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.
Topics: Contraceptives, Oral, Combined; Double-Blind Method; Endometriosis; Female; Humans; Nandrolone; Pilot Projects | 2022 |
Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain.
Topics: Chronic Pain; Contraceptives, Oral, Combined; Endometriosis; Estradiol; Female; Humans; Male; Megestrol; Nandrolone; Norpregnadienes; Pelvic Pain; Quality of Life | 2022 |
Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence of endometriosis after laparoscopic surgery.
Topics: Endometriosis; Female; Humans; Laparoscopy; Medroxyprogesterone Acetate; Nandrolone; Pelvic Pain | 2023 |
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
Topics: Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Male; Nandrolone; Norethindrone; Norethindrone Acetate | 2023 |
Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Topics: Adenomyosis; Female; Humans; Levonorgestrel; Nandrolone; Pain | 2023 |
233 other study(ies) available for nandrolone and dienogest
| Article | Year |
|---|---|
Effect of fertility regulating agents on motility and zona-free hamster egg penetration by spermatozoa of bonnet monkey.
Topics: Animals; Contraceptive Agents, Male; Cricetinae; Female; Fertility; Follicle Stimulating Hormone; Macaca radiata; Male; Nandrolone; Ovum; Sperm Motility; Sperm-Ovum Interactions; Testosterone; Zona Pellucida | 1992 |
Effects of STS-557 and 20 Aet-1 on sperm functions and serum level of testosterone in bonnet monkey (Macaca radiata).
Topics: Animals; Contraceptive Agents, Male; Macaca radiata; Male; Nandrolone; Oligospermia; Sperm Count; Sperm Motility; Spermatozoa; Testosterone; Time Factors | 1992 |
[Pharmacokinetics of contraceptive steroids with reference to long-term administration].
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menstrual Cycle; Middle Aged; Nandrolone; Norgestrel; Reference Values | 1991 |
Modulation of steroid production in goat ovarian cells: effect of progestins and antiprogestins.
Topics: Androstenedione; Androstenols; Animals; Corpus Luteum; Estradiol; Estrenes; Female; Follicle Stimulating Hormone; Gestrinone; Goats; Granulosa Cells; Nandrolone; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Promegestone | 1990 |
Effect of STS-557 (17 alpha-cyanomethyl 17 beta-hydroxy-estra-4, 9(10)-dien-3-one) on blood hormone levels, the testis, accessory sex organs and fertility of rats.
Topics: Animals; Contraceptive Agents, Male; Female; Fertility; Follicle Stimulating Hormone; Genitalia, Male; Hormones; Luteinizing Hormone; Male; Nandrolone; Random Allocation; Rats; Sperm Count; Sperm Motility; Testis; Testosterone | 1990 |
[Effect of a new gestagen--dienogest--and its combination with ethinyl estradiol on the activity of biotransformation reactions].
Topics: Adult; Biotransformation; Caffeine; Contraceptives, Oral; Dipyrone; Estradiol; Ethinyl Estradiol; Female; Humans; Metabolic Clearance Rate; Nandrolone; Progesterone | 1990 |
Contraceptive potentiality of STS-557--a feasibility study in male bonnet monkey (Macaca radiata).
Topics: Acid Phosphatase; Acrosin; Animals; Contraceptives, Oral; Dose-Response Relationship, Drug; Female; Fertility; Fructose; Glycerylphosphorylcholine; Hyaluronoglucosaminidase; Injections, Intramuscular; Male; Nandrolone; Progestins; Rabbits; Semen; Sperm Count; Sperm Motility; Sperm-Ovum Interactions; Spermatozoa; Testosterone | 1990 |
Effect of antiandrogens on some key enzymes of glycolysis in epididymis and ventral prostate of rat.
Topics: Androgen Antagonists; Animals; Body Weight; Cyproterone; Cyproterone Acetate; Enzymes; Epididymis; Estradiol; Flutamide; Glycolysis; Male; Nandrolone; Organ Size; Prostate; Rats | 1989 |
Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
Topics: Animals; Bile; Enterohepatic Circulation; Feces; Female; Intestine, Small; Nandrolone; Progesterone Congeners; Rabbits | 1989 |
Studies on the biotransformation of the progestagen dienogest in the rabbit.
Topics: Animals; Bile; Biotransformation; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Female; Nandrolone; Progesterone Congeners; Rabbits | 1989 |
Lipid metabolism during treatment of endometriosis with the progestin dienogest.
Topics: Adolescent; Adult; Endometriosis; Female; Humans; Lipid Metabolism; Middle Aged; Nandrolone | 1989 |
Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest.
Topics: Adolescent; Adult; Blood Glucose; Endometriosis; Female; Glucose Tolerance Test; Humans; Insulin; Nandrolone; Progesterone Congeners | 1989 |
[The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
Topics: Adult; Contraceptives, Oral, Combined; Cytosol; Dose-Response Relationship, Drug; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menstrual Cycle; Nandrolone; Norgestrel; Ovulation; Receptors, Progesterone | 1989 |
[Behavior of parameters of liver metabolism in intermediate-term use of the gestagen dienogest in the treatment of endometriosis].
Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Humans; Liver Function Tests; Middle Aged; Nandrolone; Progesterone Congeners; Uterine Neoplasms | 1989 |
Interaction of antiprogestins with progesterone receptors in rat uterus.
Topics: Animals; Female; Nandrolone; Progestins; Rats; Receptors, Progesterone; Steroids; Uterus | 1989 |
Synthetic antiprogestins stimulate human granulosa cell estradiol production in vitro.
Topics: Adult; Androstenedione; Estradiol; Estrenes; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; In Vitro Techniques; Luteinizing Hormone; Middle Aged; Nandrolone; Progestins | 1987 |
Effects of STS 557 on semen and sperm functions in bonnet monkey (Macaca radiata)--a preliminary report.
Topics: Acid Phosphatase; Animals; Contraceptive Agents, Male; Macaca radiata; Male; Nandrolone; Semen; Sperm Motility; Spermatozoa; Testosterone | 1988 |
Evaluation of STS-557 as an oral contraceptive in male rat.
Topics: Animals; Contraceptive Agents, Male; Dose-Response Relationship, Drug; Epididymis; Genitalia, Male; Male; Nandrolone; Organ Size; Rats; Rats, Inbred Strains; Testis; Testosterone | 1987 |
[Radioimmunologic determination of the progestagen dienogest in plasma and saliva].
Topics: Administration, Oral; Humans; Kinetics; Nandrolone; Progesterone Congeners; Radioimmunoassay; Saliva | 1986 |
[Therapy of endometriosis with dienogest].
Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Middle Aged; Nandrolone; Progesterone Congeners | 1987 |
[Bovine serum albumin conjugates of the new progestagen dienogest, synthesis and immunogenic properties].
Topics: Animals; Cattle; Immunization; Nandrolone; Progesterone Congeners; Radioimmunoassay; Serum Albumin, Bovine | 1986 |
[Radioimmunoassay of the progestagen dienogest using various methods of sample preparation of plasma].
Topics: Chromatography, High Pressure Liquid; Humans; Nandrolone; Progesterone Congeners; Radioimmunoassay; Specimen Handling | 1986 |
[Chromosome analysis of female baboons following treatment with STS 557 and levonorgestrel].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Nandrolone; Norgestrel; Papio; Progesterone Congeners; Stereoisomerism | 1985 |
Effects of antifertility estrogens and progestins on the endometrial surface of early pregnant rats. A scanning electron microscopic study.
Topics: Animals; Contraceptives, Oral, Combined; Endometrium; Estriol; Estrogens; Female; Levonorgestrel; Mestranol; Microscopy, Electron, Scanning; Microvilli; Nandrolone; Norgestrel; Pregnancy; Pregnancy, Animal; Progestins; Rats; Rats, Inbred Strains | 1985 |
Effects of the new progestagen STS 557 on the biosynthesis of steroids in tissue slices of the human ovary.
Topics: Carbon Radioisotopes; Female; Gonadal Steroid Hormones; Humans; In Vitro Techniques; Nandrolone; Ovary; Pregnenolone; Progesterone Congeners | 1985 |
Progestagenic and antigonadotrophic activities of STS 557.
Topics: Administration, Oral; Animals; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Gonadotropins; Injections, Subcutaneous; Levonorgestrel; Nandrolone; Norethindrone; Norgestrel; Ovulation; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1983 |
Receptor binding of STS 557.
Topics: Animals; Chickens; Endometrium; Female; Humans; In Vitro Techniques; Kinetics; Nandrolone; Oviducts; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Cell Surface; Receptors, Progesterone | 1983 |
Investigations on the mutagenic activity of STS 557.
Topics: Animals; Bone Marrow Cells; Chromosomes; DNA Repair; Female; Male; Mice; Mitochondria, Liver; Mutagenicity Tests; Mutagens; Nandrolone; Progesterone Congeners; Proteus mirabilis; Salmonella | 1983 |
Interceptive activities of STS 557 in rabbits, mice and rats.
Topics: Amine Oxidase (Copper-Containing); Animals; Blastocyst; Contraceptive Agents, Female; Embryo Implantation; Fallopian Tubes; Female; Fertility; Male; Mice; Nandrolone; Pregnancy; Progesterone; Progesterone Congeners; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains; Species Specificity | 1983 |
Inhibition of male fertility by STS 557.
Topics: Animals; Contraceptives, Oral, Combined; Fertility; Fructose; Gonadotropins; Levonorgestrel; Male; Nandrolone; Norgestrel; Rabbits; Reproduction; Semen; Sialic Acids; Sperm Motility; Testosterone | 1983 |
Pharmacological activities of the progestin STS 557.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Body Temperature; Contraceptives, Oral, Combined; Dogs; Drinking; Eating; Guinea Pigs; Hemodynamics; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Muscle, Smooth; Nandrolone; Norgestrel; Progesterone Congeners; Rats | 1983 |
Data on acute toxicity of the progestin STS 557.
Topics: Animals; Body Temperature; Body Weight; Contraceptives, Oral, Combined; Drinking; Eating; Female; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Nandrolone; Norgestrel; Progesterone Congeners; Rabbits; Species Specificity | 1983 |
Long term toxicological studies on the progestin STS 557.
Topics: Animals; Body Weight; Contraceptives, Oral, Combined; Dogs; Eating; Female; Glucose Tolerance Test; Hormones; Levonorgestrel; Male; Nandrolone; Norgestrel; Organ Size; Progesterone Congeners; Rats; Time Factors | 1983 |
STS 557 as an interceptive in baboons.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Levonorgestrel; Menstruation; Nandrolone; Norgestrel; Papio; Progesterone; Progesterone Congeners | 1983 |
Influence of STS 557 on the mitotic activity in the endometrium of ovariectomized mice and comparison with the effects of progesterone and levonorgestrel.
Topics: Animals; Castration; Contraceptives, Oral; Contraceptives, Oral, Combined; Endometrium; Female; Levonorgestrel; Mice; Mitosis; Nandrolone; Norgestrel; Progesterone | 1984 |
The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive.
Topics: Adult; Body Temperature; Contraceptives, Postcoital; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Nandrolone; Ovary; Pituitary Gland; Progesterone | 1984 |
On the effect of the new progestagen dienogest (STS 557) on the proliferative responses of rabbit blood lymphocytes to mitogens.
Topics: Animals; Concanavalin A; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Mitogens; Nandrolone; Phytohemagglutinins; Progesterone Congeners; Rabbits | 1984 |
Fertilizing ability of spermatozoa of rats treated with STS 557.
Topics: Animals; Contraceptives, Oral; Female; Fertility; Fructose; Male; Nandrolone; Rats; Semen; Sperm Motility; Spermatozoa | 1983 |
Urinary metabolites of the new progestagen STS 557 (17 alpha-cyanomethyl-17-hydroxy-4,9-estradien-3-one) in the dog and rat.
Topics: Administration, Oral; Animals; Chromatography, Thin Layer; Dogs; Female; Kinetics; Male; Mass Spectrometry; Nandrolone; Progesterone Congeners; Rats; Rats, Inbred Strains; Species Specificity; Spectrophotometry, Ultraviolet | 1983 |
Preclinical data on STS 557.
Topics: Animals; Nandrolone; Progesterone Congeners | 1983 |
Preclinical data on STS 557. Introduction.
Topics: Animals; Chemical Phenomena; Chemistry; Nandrolone; Progesterone Congeners | 1983 |
The synthetic approach to STS 557 - structure activity relationships in 17 alpha-CH2X-substituted 19-nortestosterone derivatives.
Topics: Animals; Female; Nandrolone; Progesterone Congeners; Rabbits; Structure-Activity Relationship | 1983 |
Studies on pharmacokinetics of STS 557 in animal species and man.
Topics: Animals; Blood Proteins; Dogs; Female; Humans; Kinetics; Male; Nandrolone; Papio; Progesterone Congeners; Protein Binding; Rats; Species Specificity | 1983 |
Studies on biotransformation of STS 557.
Topics: Animals; Bacteria; Biotransformation; Clostridium; Female; In Vitro Techniques; Microsomes, Liver; Mycobacterium; Nandrolone; Progesterone Congeners; Rats; Rhodotorula | 1983 |
Prenatal toxic effects of STS 557. I. Investigations in mice.
Topics: Animals; Body Weight; Embryo, Mammalian; Female; Fetus; Mice; Nandrolone; Pregnancy; Progesterone Congeners; Teratogens | 1983 |
Prenatal toxic effects of STS 557. II. Investigation in rabbits--preliminary results.
Topics: Abnormalities, Drug-Induced; Animals; Corpus Luteum; Estrus; Female; Fetal Resorption; Nandrolone; Pregnancy; Progesterone Congeners; Rabbits | 1983 |
Influence of a 9-double bond on stereospecific microbial 4,5-reductions.
Topics: Clostridium; Mitosporic Fungi; Nandrolone; Rhodotorula; Species Specificity; Stereoisomerism; Structure-Activity Relationship | 1983 |
Effects of levonorgestrel and STS 557 on testis in rodents.
Topics: Animals; Castration; DNA; Female; Fertility; Levonorgestrel; Libido; Luteinizing Hormone; Male; Nandrolone; Norgestrel; Organ Size; Pregnancy; Rats; Sexual Maturation; Testis | 1980 |
[Chromosomal analysis of baboons and their mothers, following application to mothers of potentially post-ovulation fertility-inhibiting steroids (author's transl)].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Chromosome Mapping; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Levonorgestrel; Lymphocytes; Nandrolone; Norgestrel; Papio; Pregnancy | 1981 |
Toxicity of the progestagen STS 557 compared to levonorgestrel in beagles after oral administration for 6 months.
Topics: 11-Hydroxycorticosteroids; Administration, Oral; Animals; Dogs; Female; Levonorgestrel; Male; Nandrolone; Norgestrel; Progesterone Congeners; Time Factors | 1982 |
Further report on the interceptive STS 557 in baboons.
Topics: Administration, Oral; Animals; Contraceptives, Oral, Combined; Female; Levonorgestrel; Nandrolone; Norgestrel; Papio; Pregnancy; Progesterone | 1982 |
[Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens].
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dogs; Estrus; Female; Levonorgestrel; Long-Term Care; Menstruation; Nandrolone; Norgestrel; Pregnancy; Vaginal Smears | 1982 |
Further report on the endocrinological profile of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one (STS 557) in rodents.
Topics: Animals; Contraceptives, Oral; Female; Mice; Nandrolone; Organ Size; Ovary; Pregnancy; Pregnancy, Animal; Progesterone Congeners; Rats; Rats, Inbred Strains; Rodentia; Uterus; Vagina | 1982 |
Microbial transformation of 17 alpha-cyanomethyl-17-hydroxy-4,9-estradien-3-one (STS 557) and 17 alpha-cyanomethyl-19-nortestosterone by Mycobacterium smegmatis.
Topics: Biotransformation; Chemical Phenomena; Chemistry; Hydrogenation; Mycobacterium; Nandrolone | 1982 |
Evaluation of STS-557 as a postcoital contraceptive in the baboon.
Topics: Animals; Contraceptives, Oral; Contraceptives, Postcoital; Estradiol; Female; Nandrolone; Papio; Progesterone; Progesterone Congeners | 1981 |
STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits.
Topics: Animals; Contraceptives, Oral; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estrenes; Female; Fertilization; Nandrolone; Norgestrel; Ovary; Ovum Transport; Pregnancy; Progesterone Congeners; Rabbits; Receptors, Progesterone | 1980 |
[The endocrinologic profile of metabolites of the progestin dienogest].
Topics: Androgen Antagonists; Animals; Endometrium; Estradiol Congeners; Female; Fertility; In Vitro Techniques; Male; Mice; Nandrolone; Pregnancy; Progestins; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1993 |
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Mice; Mice, SCID; Nandrolone; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1997 |
Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
Topics: Animals; Carbonic Anhydrases; Castration; Cell Division; Contraceptives, Oral; Endometriosis; Endometrium; Enzyme Induction; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovulation; Rabbits; Rats; Receptors, Progesterone; Receptors, Steroid; Sex Hormone-Binding Globulin | 1997 |
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
Topics: Animals; Buserelin; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Immunity, Cellular; Interleukin-1; Killer Cells, Natural; Macrophages, Peritoneal; Nandrolone; Progesterone; Progesterone Congeners; Protein Kinase C; Rats; Rats, Sprague-Dawley | 1998 |
Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins.
Topics: Animals; Aorta, Thoracic; Chlormadinone Acetate; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Hormone Antagonists; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nandrolone; Norethindrone; Phenylephrine; Progesterone; Progesterone Congeners; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1997 |
Effects of dienogest (a synthetic steroid) on coagulation, fibrinolysis, and platelet aggregation in female monkeys.
Topics: Animals; Blood Coagulation; Blood Platelets; Cholesterol; Danazol; Female; Fibrinolysis; Hormone Antagonists; Macaca fascicularis; Macaca mulatta; Medroxyprogesterone Acetate; Nandrolone; Phospholipids; Platelet Aggregation | 1998 |
Effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats.
Topics: Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Cholesterol; Contraceptives, Oral; Danazol; Female; Fibrinolysis; Lipids; Medroxyprogesterone Acetate; Nandrolone; Phospholipids; Platelet Aggregation; Rats | 1999 |
Effect of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4, 9-dien-3-one on reproductive organs of the male laboratory mouse.
Topics: Animals; Genitalia, Male; Male; Mice; N-Acetylneuraminic Acid; Nandrolone; Organ Size; Progesterone Congeners; Spermatozoa; Testis | 1998 |
Endometriosis: a clinically malignant disease.
Topics: Adult; Colonic Diseases; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Obstruction; Nandrolone; Rectal Diseases; Uremia; Ureteral Obstruction | 1999 |
Nitrile hydratase from Rhodococcus erythropolis: metabolization of steroidal compounds with a nitrile group.
Topics: Animals; Biotransformation; Drug Evaluation, Preclinical; Estradiol; Fermentation; Hydro-Lyases; Hydrolysis; Nandrolone; Progesterone; Pyridines; Rabbits; Receptors, Estrogen; Rhodococcus; Structure-Activity Relationship | 1999 |
The efficacy and tolerability of Valette: a postmarketing surveillance study.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Germany; Hormone Antagonists; Humans; Liver; Menstruation; Nandrolone; Pregnancy; Product Surveillance, Postmarketing; Pulmonary Embolism; Thrombosis | 1999 |
Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Cell Division; Chorion; Depression, Chemical; Embryo, Mammalian; Endothelium, Vascular; Female; Mice; Mice, Inbred ICR; Microcirculation; Nandrolone; Neovascularization, Pathologic; Neovascularization, Physiologic; Plasminogen Activators; Regional Blood Flow; Tumor Cells, Cultured | 1999 |
Influence of sexual steroids on cell functions of PMNL in the gingival sulcus.
Topics: Candida albicans; Cell Count; Estradiol; Gingiva; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Nandrolone; Neutrophils; Periodontitis; Phagocytosis | 2000 |
Growth-stimulating effect of dienogest, a synthetic steroid, on rodent, canine, and primate mammary glands.
Topics: Animals; Cells, Cultured; Dogs; Epithelium; Female; Hormone Antagonists; Human Growth Hormone; Humans; Immunohistochemistry; Macaca mulatta; Mammary Glands, Animal; Medroxyprogesterone Acetate; Nandrolone; Progesterone Congeners; Rats; Stimulation, Chemical | 2000 |
Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Contraceptives, Oral; Dose-Response Relationship, Drug; Female; Humans; Hyperandrogenism; Nandrolone; Norgestrel; Progestins; Receptors, Androgen; Skin | 2000 |
The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.
Topics: Cell Division; Cells, Cultured; Contraceptives, Oral; Endometrium; Estradiol; Female; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Nandrolone; Progesterone; Prolactin; Steroids | 2001 |
Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat and Valette.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Levonorgestrel; Nandrolone; Protein Binding; Radioimmunoassay; Saliva; Ultrafiltration | 2001 |
[Endometriosis of the lungs: analysis of diagnosis and therapy].
Topics: Adolescent; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Lung Diseases; Nandrolone; Thoracotomy | 2001 |
Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women.
Topics: Adult; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Galanin; Humans; Levonorgestrel; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
Topics: Adult; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Estrogens, Catechol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
Treatment of menstruation-associated recurrence of hereditary pancreatitis with pharmacologic ovarian suppression.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Estradiol; Female; Follow-Up Studies; Genetic Diseases, Inborn; Humans; Menstrual Cycle; Nandrolone; Ovary; Pancreatitis; Recurrence; Risk Assessment; Treatment Outcome | 2002 |
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2002 |
Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women.
Topics: Estradiol; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2002 |
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.
Topics: Adolescent; Adult; Breast Diseases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP1A1; Depression; Drug Administration Schedule; Female; Gastrointestinal Diseases; Headache; Humans; Nandrolone; Prospective Studies; Skin Diseases; Steroid Hydroxylases; Treatment Failure; Treatment Outcome | 2002 |
[Hormone use in migraine].
Topics: Adult; Chronic Disease; Contraceptives, Oral; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Migraine Disorders; Nandrolone; Ovulation Inhibition; Recurrence; Time Factors | 2003 |
Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.
Topics: Adolescent; Adult; Attitude of Health Personnel; Contraceptives, Oral; Female; Germany; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Menstrual Cycle; Menstruation; Middle Aged; Nandrolone; Physicians; Pregnancy; Surveys and Questionnaires; Women | 2004 |
Endogenous estradiol metabolism during treatment with oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic | 2004 |
DNA fragmentation, DNA repair and apoptosis induced in primary rat hepatocytes by dienogest, dydrogesterone and 1,4,6-androstatriene-17beta-ol-3-one acetate.
Topics: Androstatrienes; Animals; Apoptosis; Aromatase Inhibitors; Cells, Cultured; DNA; DNA Fragmentation; DNA Repair; Dydrogesterone; Female; Hepatocytes; Hormone Antagonists; Male; Molecular Structure; Mutagenicity Tests; Nandrolone; Rats; Rats, Sprague-Dawley | 2004 |
Progestins and estrogens and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Cognition; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Progesterone Congeners; Rats | 2005 |
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men.
Topics: Adult; Androgens; Anthropometry; Blood Pressure; Body Weight; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Estradiol; Ghrelin; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Nandrolone; Peptide Hormones; Testosterone | 2005 |
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Statistics, Nonparametric; Treatment Outcome | 2006 |
Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells.
Topics: Adult; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cells, Cultured; Contraceptives, Oral; DNA; Drug Evaluation, Preclinical; Endometriosis; Female; G1 Phase; Humans; Nandrolone; Ovarian Diseases; Resting Phase, Cell Cycle; Stromal Cells | 2008 |
Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Androgen Antagonists; Androstenes; Case-Control Studies; Chlormadinone Acetate; Clobetasol; Contraceptives, Oral; Cyproterone Acetate; Female; Glucocorticoids; Humans; Imiquimod; Incidence; Nandrolone; Premenopause; Progesterone; Retrospective Studies; Risk Factors; Treatment Outcome; Vulvar Lichen Sclerosus | 2008 |
Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Topics: Androgen Receptor Antagonists; Animals; Endometrium; Female; Humans; Nandrolone; Rabbits; Receptors, Androgen; Receptors, Progesterone; Receptors, Steroid | 2008 |
Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys.
Topics: Animals; Apoptosis; Estradiol; Female; Follicle Stimulating Hormone; Follicular Atresia; Granulosa Cells; Hormone Antagonists; Humans; Macaca fascicularis; Menstrual Cycle; Nandrolone; Ovarian Follicle; Progesterone; Progestins | 2008 |
Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.
Topics: alpha-Glucosidases; Animals; Apoptosis; Blood Chemical Analysis; Contraception; Contraceptive Agents, Male; Epididymis; Female; Histocytochemistry; In Situ Nick-End Labeling; Injections, Intravenous; Litter Size; Male; Nandrolone; Pregnancy; Rats; Rats, Wistar; Sperm Count; Spermatogenesis; Testis; Testosterone | 2009 |
Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
Topics: Blotting, Western; Cell Cycle; Cell Line; Cyclin D1; Cyclin E; Endometrium; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Immunohistochemistry; Nandrolone; Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Why use of dienogest for the first contraceptive pill with estradiol?
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Middle Aged; Nandrolone; Young Adult | 2010 |
After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; History, 20th Century; Humans; Nandrolone; Progestins | 2010 |
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult | 2010 |
Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model.
Topics: Animals; Endometriosis; Endometrium; Female; Hemodynamics; Nandrolone; Neovascularization, Physiologic; Rats; Rats, Wistar | 2010 |
Natazia--a new oral contraceptive.
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Approval; Estradiol; Female; Humans; Nandrolone; United States; United States Food and Drug Administration | 2010 |
Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system.
Topics: Aromatase; Cell Culture Techniques; Cells, Cultured; Dinoprostone; Endometrium; Epithelial Cells; Female; Humans; Nandrolone; Reverse Transcriptase Polymerase Chain Reaction; Spheroids, Cellular | 2011 |
[Evaluation of obesity in a 22-year-old female patient].
Topics: Blood Sedimentation; Contraceptives, Oral, Combined; Cushing Syndrome; Dexamethasone; Diagnosis, Differential; Ethinyl Estradiol; Female; Giant Cell Arteritis; Headache; Humans; Hydrocortisone; Nandrolone; Obesity, Morbid; Predictive Value of Tests; Young Adult | 2010 |
Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Topics: Adult; Antineoplastic Agents, Hormonal; Case-Control Studies; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leiomyoma; Leuprolide; Middle Aged; Nandrolone; Premenopause; Retrospective Studies; Tumor Burden; Uterine Neoplasms | 2011 |
Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pilot Projects; Rectal Diseases; Retrospective Studies; Sigmoid Diseases; Urinary Bladder Diseases | 2011 |
Oral contraceptives and heavy periods.
Topics: Contraceptives, Oral; Estradiol; Female; Humans; Menorrhagia; Nandrolone | 2011 |
Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pregnancy; Urinary Bladder; Urinary Bladder Diseases | 2011 |
Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding.
Topics: Contraceptive Agents; Contraceptives, Oral; Drug Combinations; Drug Evaluation; Estradiol; Female; Humans; Menorrhagia; Nandrolone; Randomized Controlled Trials as Topic | 2011 |
Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration.
Topics: Animals; Danazol; Disease Models, Animal; Endometriosis; Endometrium; Female; Hormone Antagonists; Nandrolone; Ovary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Treatment Outcome; Uterus; Vascular Endothelial Growth Factor A | 2011 |
Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Endometrium; Epithelial Cells; Female; Gene Expression Regulation; Gene Knockdown Techniques; HMGB1 Protein; Hormone Antagonists; Humans; Interleukin-8; Lipopolysaccharides; Nandrolone; RNA, Small Interfering; Toll-Like Receptor 4 | 2011 |
Extended intervention time and evaluation of sperm suppression by dienogest plus testosterone undecanoate in male rat.
Topics: Androgens; Animals; Apoptosis; Contraceptive Agents, Male; Hormones; Male; Nandrolone; Rats; Rats, Wistar; Spermatogenesis; Testosterone | 2012 |
Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
Topics: Adult; Aromatase; Aromatase Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Nandrolone; NF-kappa B; Ovarian Diseases; Ovary; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spheroids, Cellular; Stromal Cells; Young Adult | 2012 |
Dienogest. Endometriosis: still no progress.
Topics: Endometriosis; Female; Humans; Nandrolone | 2011 |
Complete sperm suppression induced by dienogest plus testosterone undecanoate is associated with down-regulation in the expression of upstream steroidogenic enzyme genes in rat testis.
Topics: 3-Hydroxysteroid Dehydrogenases; Androgens; Animals; Cholesterol Side-Chain Cleavage Enzyme; Contraceptive Agents, Male; Down-Regulation; Drug Synergism; Injections, Intramuscular; Male; Nandrolone; Organ Size; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger; Seminiferous Tubules; Spermatogenesis; Spermatogonia; Steroid 17-alpha-Hydroxylase; Testis; Testosterone | 2012 |
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest.
Topics: Adult; Endometriosis; Female; Hemoglobins; Humans; Middle Aged; Nandrolone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Uterine Hemorrhage | 2012 |
Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line.
Topics: Aromatase; Cell Line; Cell Membrane; Cell Nucleus; Dydrogesterone; Endometriosis; Epithelial Cells; Estradiol; Estradiol Dehydrogenases; Estrogen Receptor alpha; Female; Gene Expression Regulation, Enzymologic; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2012 |
Effective salvage of acute massive uterine bleeding using intrauterine balloon tamponade in a uterine adenomyosis patient on dienogest.
Topics: Adenomyosis; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Nandrolone; Uterine Balloon Tamponade; Uterine Hemorrhage | 2013 |
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins | 2013 |
Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aldo-Keto Reductase Family 1 Member C3; Cells, Cultured; Down-Regulation; Dydrogesterone; Endometriosis; Endometrium; Epithelial Cells; Estradiol Dehydrogenases; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Progesterone; Progestins; Receptors, Progesterone; RNA, Messenger | 2013 |
Complete sperm suppression in rats with dienogest plus testosterone undecanoate is facilitated through apoptosis in testicular cells.
Topics: Animals; Apoptosis; Drug Therapy, Combination; Male; Nandrolone; Rats; Rats, Wistar; Spermatozoa; Testis; Testosterone | 2013 |
Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.
Topics: Administration, Oral; Adult; Contraceptives, Oral; Female; Half-Life; Humans; Metabolic Clearance Rate; Nandrolone; Progestins; Reproducibility of Results; Republic of Korea; Tablets; Young Adult | 2013 |
Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Topics: Adult; Analgesics; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Dysmenorrhea; Estradiol; Female; Humans; Italy; Menstruation; Migraine Disorders; Nandrolone; Pilot Projects; Prospective Studies; Treatment Outcome | 2013 |
Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Italy; Nandrolone; Overweight; Polycystic Ovary Syndrome; Young Adult | 2013 |
Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
Topics: Absorptiometry, Photon; Adult; Amino Acids; Bone and Bones; Bone Density; Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estradiol; Female; Humans; Lumbar Vertebrae; Nandrolone; Osteocalcin; Time Factors; Young Adult | 2013 |
[Endometriosis, an underestimated disease: reducing pelvic pain effectively and lastingly].
Topics: Analgesics; Contraceptives, Oral; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Treatment Outcome | 2013 |
Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study.
Topics: Acne Vulgaris; Adolescent; Androgens; Contraceptives, Oral, Hormonal; Estradiol; Female; Humans; Longitudinal Studies; Nandrolone; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Young Adult | 2013 |
Effect of a dienogest for an experimental three-dimensional endometrial culture model for endometriosis.
Topics: Adult; Apoptosis; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Endometriosis; Endometrium; Epithelial Cells; Female; Hormone Antagonists; Humans; Middle Aged; Models, Biological; Nandrolone; Tissue Culture Techniques | 2014 |
Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β.
Topics: Animals; Cell Line, Transformed; Female; Hormone Antagonists; Humans; Inflammation Mediators; Interleukin-1beta; Nandrolone; Nerve Growth Factor; PC12 Cells; Prospective Studies; Rats; Tumor Necrosis Factor-alpha; Up-Regulation | 2014 |
Surgery versus pharmacological treatment for endometriosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Nandrolone; Pelvic Pain; Progestins | 2014 |
Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis.
Topics: Adult; Ascitic Fluid; Cells, Cultured; Endometriosis; Female; HLA-DR Antigens; Hormone Antagonists; Humans; Macrophages; Nandrolone; Peritoneal Diseases; Tumor Necrosis Factor-alpha | 2014 |
Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Case-Control Studies; Cell Proliferation; Endometriosis; Female; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Nandrolone; Neovascularization, Pathologic; von Willebrand Factor | 2014 |
Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers, Pharmacological; Diffusion; Diffusion Magnetic Resonance Imaging; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Cysts; Predictive Value of Tests; Prognosis; Retrospective Studies | 2014 |
A simple, rapid and sensitive liquid chromatography-tandem mass spectrometry method for the determination of dienogest in human plasma and its pharmacokinetic applications under fasting.
Topics: Chromatography, Liquid; Humans; Nandrolone; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
Topics: Adenomyosis; Adult; Female; Humans; Metrorrhagia; Middle Aged; Nandrolone; Pilot Projects; Progesterone Congeners; Treatment Outcome | 2014 |
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
Topics: Adult; Body Composition; Chlormadinone Acetate; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Metabolism; Nandrolone; Prospective Studies | 2014 |
Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells.
Topics: Adenomyosis; Adult; Apoptosis; Cell Proliferation; Cells, Cultured; Endometrium; Estradiol; Female; Humans; Middle Aged; Nandrolone; Progesterone; Stromal Cells | 2014 |
Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
Topics: Adult; Drug Administration Schedule; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Endometriosis associated with relapsing ascites and pleural effusions.
Topics: Adult; Ascites; Endometriosis; Female; Hormone Antagonists; Humans; Leuprolide; Nandrolone; Ovarian Cysts; Paracentesis; Peritoneal Cavity; Pleura; Pleural Effusion; Treatment Outcome | 2015 |
Urinary incontinence and bladder endometriosis: conservative management.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Nandrolone; Urinary Bladder Diseases; Urinary Incontinence | 2015 |
Decorin induced by progesterone plays a crucial role in suppressing endometriosis.
Topics: Adult; Cell Cycle; Cells, Cultured; Cross-Sectional Studies; Decorin; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Progesterone; Retrospective Studies; Transcriptional Activation; Young Adult | 2014 |
Effects of estradiol valerate and dienogest on quality of life and sexual function according to age.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Libido; Middle Aged; Nandrolone; Personal Satisfaction; Quality of Life; Sexual Behavior; Surveys and Questionnaires | 2014 |
Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Fertility Agents; Gonadotropin-Releasing Hormone; Infertility, Female; Male; Nandrolone; Ovarian Follicle; Ovary; Pregnancy; Rats, Sprague-Dawley | 2015 |
Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
Topics: Aromatase; Cell Line; Cytokines; Down-Regulation; Endometriosis; Female; Humans; Intramolecular Oxidoreductases; Nandrolone; Nerve Growth Factor; Progesterone Congeners; Prostaglandin-E Synthases; Receptors, Progesterone; RNA, Messenger; Vascular Endothelial Growth Factor A | 2015 |
Dienogest reduces HSD17β1 expression and activity in endometriosis.
Topics: Adult; Aromatase; Cells, Cultured; Endometriosis; Endometrium; Estradiol Dehydrogenases; Female; Gene Expression Regulation, Enzymologic; Humans; Nandrolone; Young Adult | 2015 |
Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
Topics: Adult; Cohort Studies; Dysuria; Endometriosis; Female; Hematuria; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Quality of Life; Treatment Outcome; Ultrasonography; Urinary Bladder Diseases | 2015 |
Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts.
Topics: Adult; Anti-Mullerian Hormone; Endometriosis; Female; Humans; Laparoscopy; Leuprolide; Nandrolone; Ovarian Cysts; Ovary; Visual Analog Scale | 2015 |
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
Topics: Adenomyosis; Administration, Oral; Adult; Endometriosis; Female; Humans; Injections, Subcutaneous; Menorrhagia; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Prospective Studies; Treatment Outcome; Triptorelin Pamoate | 2015 |
Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR.
Topics: Apoptosis; Autophagy; Cells, Cultured; Endometriosis; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nandrolone; Ovarian Cysts; Phosphorylation; Progesterone; Proto-Oncogene Proteins c-akt; Signal Transduction; Stromal Cells; TOR Serine-Threonine Kinases | 2015 |
Outcomes of treatment with cyclic administration of dienogest after ovarian endometriotic cystectomy.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Female; Humans; Laparoscopy; Nandrolone; Ovarian Cysts; Pelvic Pain; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.
Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Nandrolone; Orgasm; Pelvic Pain; Quality of Life; Sexual Behavior; Treatment Outcome; Young Adult | 2015 |
Use of dienogest over 53 weeks for the treatment of endometriosis.
Topics: Adult; CA-125 Antigen; Endometriosis; Estradiol; Female; Humans; Membrane Proteins; Middle Aged; Nandrolone | 2015 |
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.
Topics: Adult; Cost-Benefit Analysis; Drug Costs; Drug Substitution; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Progestins; Quality of Life; Treatment Outcome | 2016 |
Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Endometrial Neoplasms; Female; Medroxyprogesterone Acetate; Mice; Nandrolone; Progestins; Treatment Outcome | 2016 |
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
Topics: Adult; Disease-Free Survival; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Japan; Laparoscopy; Nandrolone; Outcome Assessment, Health Care; Ovarian Diseases; Pain Measurement; Pelvic Pain; Recurrence; Retrospective Studies | 2016 |
Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prognosis; Prospective Studies; Quality of Life; Sexual Behavior; Young Adult | 2016 |
Primary umbilical endometriosis successfully treated with dienogest.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Umbilicus | 2017 |
Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Nandrolone; Patient Reported Outcome Measures; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; United States; Venous Thromboembolism; Young Adult | 2016 |
Dienogest mediates midkine suppression in endometriosis.
Topics: Adult; Ascitic Fluid; Cells, Cultured; Cytokines; Down-Regulation; Drug Discovery; Endometriosis; Endometrium; Female; Hormone Antagonists; Humans; Midkine; Nandrolone; Prospective Studies; Stromal Cells | 2016 |
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha | 2016 |
Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
Topics: Adult; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Nandrolone; Pelvic Pain; Recurrence | 2016 |
Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis.
Topics: Adenomyosis; Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Apoptosis; Cell Proliferation; Combined Modality Therapy; Down-Regulation; Endometrium; Female; Humans; Immunohistochemistry; Middle Aged; Myometrium; Nandrolone; Nerve Fibers; Nerve Growth Factor; Neurogenesis; Progestins | 2016 |
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Lumbar Vertebrae; Nandrolone; Pain Measurement; Pelvic Pain | 2017 |
Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission.
Topics: Adult; Constipation; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Diseases; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Treatment Outcome | 2017 |
Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density.
Topics: Absorptiometry, Photon; Adult; Bone Density; Contraceptives, Oral; Endometriosis; Female; Femur Neck; Humans; Lumbar Vertebrae; Nandrolone; Prospective Studies; Secondary Prevention | 2017 |
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha | 2017 |
Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Drug Evaluation, Preclinical; Endometriosis; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nandrolone; Rats, Wistar; Rosuvastatin Calcium | 2017 |
Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells.
Topics: Cell Line; Chemokine CCL20; Endometriosis; Epithelial Cells; Female; Humans; Interleukin-1beta; Mifepristone; Nandrolone; Receptors, Progesterone | 2017 |
Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside.
Topics: Disease Progression; Drug Design; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone | 2017 |
Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience.
Topics: Adolescent; Adult; Cohort Studies; Dyspareunia; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Treatment Outcome | 2017 |
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2017 |
Long-term use of dienogest in the treatment of painful symptoms in adenomyosis.
Topics: Adenomyosis; Adult; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone | 2017 |
Environmental photochemistry of dienogest: phototransformation to estrogenic products and increased environmental persistence via reversible photohydration.
Topics: Endocrine Disruptors; Estrogens; Kinetics; Models, Molecular; Models, Theoretical; Molecular Structure; Nandrolone; Photolysis; Ultraviolet Rays; Water Pollutants, Chemical | 2017 |
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome; Ultrasonography; Young Adult | 2018 |
Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
Topics: Adult; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Ovarian Diseases; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome | 2017 |
Treatment of premenstrual mood changes in a patient with schizophrenia using dienogest: A case report.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Premenstrual Syndrome; Schizophrenia | 2018 |
Dienogest suppresses the activation of primordial follicles and preserves the primordial follicle stockpile for fertility in mice.
Topics: Animals; Female; Fertility; Mice; Mice, Inbred ICR; Nandrolone; Ovarian Follicle; Ovary; Phosphorylation; Proto-Oncogene Proteins c-akt | 2018 |
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence | 2018 |
Complete remission of cerebral endometriosis with dienogest: a case report.
Topics: Adult; Brain; Brain Diseases; Endometriosis; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Nandrolone; Treatment Outcome | 2018 |
Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis.
Topics: Adult; Alopecia; Cross-Sectional Studies; Depression; Endometriosis; Female; Humans; Menstruation; Menstruation Disturbances; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Quality of Life; Recurrence; Republic of Korea; Surveys and Questionnaires; Time Factors; Weight Gain | 2018 |
When Solving Dyspareunia Is Not Enough to Restore Sexual Function in Women With Deep Infiltrating Endometriosis Treated With Dienogest.
Topics: Adult; Brazil; Dyspareunia; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Treatment Outcome; Young Adult | 2019 |
Long-term dienogest administration in patients with symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Female; Hormone Antagonists; Humans; Longitudinal Studies; Middle Aged; Nandrolone; Retrospective Studies | 2018 |
Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data.
Topics: Adult; Amenorrhea; CA-125 Antigen; Endometriosis; Female; Hormone Antagonists; Humans; Multicenter Studies as Topic; Nandrolone; Pain; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome | 2018 |
Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Pain, Postoperative; Pelvic Pain; Young Adult | 2018 |
Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Recurrence; Reoperation; Young Adult | 2018 |
Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Combined Modality Therapy; Dysmenorrhea; Endometrial Ablation Techniques; Female; Hormone Antagonists; Humans; Menorrhagia; Microwaves; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Retrospective Studies | 2018 |
Comparison of dienogest and progesterone effects on uterine contractility in the extracorporeal perfusion model of swine uteri.
Topics: Animals; Area Under Curve; Extracorporeal Circulation; Female; Hormone Antagonists; Nandrolone; Progesterone; Progestins; Swine; Uterine Contraction | 2018 |
Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
Topics: Adult; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pelvic Pain; Retrospective Studies | 2018 |
Effects of different progestins on prostaglandin biosynthesis in human endometrial explants.
Topics: Androstenes; Chlormadinone Acetate; Endometrium; Female; Humans; Nandrolone; Organ Culture Techniques; Progestins; Prostaglandins | 2019 |
A case of unique endoscopic findings of intestinal endometriosis exposed to the mucosa: aggregation of papillary protruded bulges from the submucosal elevation of the rectum.
Topics: Adult; Colonoscopy; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Mucosa; Nandrolone; Rectal Diseases | 2019 |
Excerpts From the World Medical Literature.
Topics: Adenomyosis; Double-Blind Method; Female; Humans; Nandrolone; Pain | 2018 |
Pain-related behavior and brain activation in cynomolgus macaques with naturally occurring endometriosis.
Topics: Acetaminophen; Analgesics; Animals; Behavior, Animal; Brain; Central Nervous System; Endometriosis; Female; Macaca fascicularis; Magnetic Resonance Imaging; Meloxicam; Morphine; Nandrolone; Pain | 2019 |
Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
Topics: Adult; Contraceptives, Oral, Combined; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nandrolone; Ovarian Diseases; Prospective Studies; Secondary Prevention; Young Adult | 2019 |
Bioactive Rearrangement Products from Aqueous Photolysis of Pharmaceutical Steroids.
Topics: Molecular Structure; Nandrolone; Pharmaceutical Preparations; Photolysis; Steroids | 2019 |
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone | 2019 |
Umbilical endometriosis (Villar's nodule).
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Umbilicus | 2019 |
Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice.
Topics: Adult; Asian People; Cohort Studies; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome | 2019 |
Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?
Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Ovarian Diseases; Retrospective Studies | 2019 |
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Pelvic Pain; Treatment Outcome; Young Adult | 2020 |
Clinical aspects and management of inguinal endometriosis: A case series of 20 patients.
Topics: Adult; Endometriosis; Female; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Inguinal Canal; Magnetic Resonance Imaging; Middle Aged; Nandrolone; Recurrence; Retrospective Studies | 2019 |
Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report.
Topics: Adnexal Diseases; Adult; Endometriosis; Female; Hemoperitoneum; Hemostasis, Surgical; Hormone Antagonists; Humans; Laparoscopy; Ligaments; Nandrolone; Severity of Illness Index | 2020 |
Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study.
Topics: Adenocarcinoma, Clear Cell; Adult; Age Factors; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Ovarian Neoplasms; Parity; Retrospective Studies; Risk Factors | 2019 |
Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Topics: Adenomyosis; Adult; Cohort Studies; Drug Administration Schedule; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Middle Aged; Nandrolone; Recurrence; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2020 |
Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Contraceptives, Oral, Hormonal; Female; Hemorrhage; Humans; Middle Aged; Nandrolone; Retrospective Studies; Risk Factors | 2019 |
Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction.
Topics: Activating Transcription Factor 4; Adult; Apoptosis; Cell Movement; Cell Proliferation; Cysts; eIF-2 Kinase; Endometriosis; Endometrium; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Gene Expression Regulation; Hormone Antagonists; Humans; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Nandrolone; Progesterone; Protein Serine-Threonine Kinases; RNA, Small Interfering; Stromal Cells; TNF Receptor-Associated Factor 2; Transcription Factor CHOP | 2020 |
Efficacy of dienogest treatment of clinical symptoms of rectovaginal endometriosis.
Topics: Cohort Studies; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Rectum; Treatment Outcome; Vagina | 2019 |
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations.
Topics: Adenomyosis; Adult; Cell Proliferation; DNA Mutational Analysis; Endometriosis; Endometrium; Female; High-Throughput Nucleotide Sequencing; Humans; Hysterectomy; Middle Aged; Mutation; Myometrium; Nandrolone; Proto-Oncogene Proteins p21(ras); Receptors, Progesterone; Treatment Outcome; Young Adult | 2019 |
Expression of Lewis (b) blood group antigen interferes with oral dienogest therapy among women with adenomyosis.
Topics: Adenomyosis; Administration, Oral; Adult; Female; Hormone Antagonists; Humans; Lewis Blood Group Antigens; Nandrolone; Quality of Life; Retrospective Studies; Treatment Outcome | 2020 |
Primary dysmenorrhea: new dose of an old medicine offers more options.
Topics: Double-Blind Method; Dysmenorrhea; Female; Humans; Medicine; Nandrolone | 2020 |
Effect of Dienogest therapy on the size of the endometrioma.
Topics: Adult; Dysmenorrhea; Dyspareunia; Endometriosis; Endometrium; Female; Humans; Italy; Middle Aged; Nandrolone; Organ Size; Pelvic Pain; Peritoneal Diseases; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2020 |
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study.
Topics: Adult; Endometriosis; Europe; Female; Germany; Hormone Antagonists; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Research Design; Women's Health | 2020 |
Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cystectomy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Middle Aged; Nandrolone; Preoperative Period; Prospective Studies; Young Adult | 2020 |
Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Retrospective Studies; Risk Factors | 2021 |
Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle.
Topics: Adult; Birth Rate; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Nandrolone; Oocyte Retrieval; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies | 2020 |
New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone.
Topics: Adult; Cohort Studies; Dydrogesterone; Endometriosis; Female; Humans; Nandrolone; Ovary; Pregnancy; Progestins; Prospective Studies | 2021 |
Identification of biomarkers for drug-resistant endometriosis using clinical proteomics.
Topics: Antimicrobial Cationic Peptides; Blood Proteins; Carcinogenesis; Cell Line; Drug Resistance; Endometriosis; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Nandrolone; Proteomics | 2021 |
The Long-Term Effect of Dienogest on Bone Mineral Density After Surgical Treatment of Endometrioma.
Topics: Adult; Bone Density; Endometriosis; Female; Humans; Nandrolone; Postoperative Complications; Retrospective Studies | 2021 |
Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis.
Topics: Adenomyosis; Endometriosis; Female; Humans; Nandrolone; Retrospective Studies | 2021 |
Dienogest reduces endometrioma volume and endometriosis-related pain symptoms.
Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstruation Disturbances; Nandrolone; Organ Size; Pain Measurement; Pelvic Pain; Prospective Studies; Treatment Outcome; Uterine Diseases | 2021 |
Successful treatment of peritoneal inclusion cysts with dienogest: two case reports.
Topics: Cysts; Endometriosis; Humans; Nandrolone; Peritoneal Diseases | 2022 |
Cost-effectiveness Analysis of Dienogest Compared With Gonadotropin-Releasing Hormone Agonist After Conservative Surgery for Endometriosis in China.
Topics: China; Cost-Benefit Analysis; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone | 2021 |
Biotransformation of Current-Use Progestin Dienogest and Drospirenone in Laboratory-Scale Activated Sludge Systems Forms High-Yield Products with Altered Endocrine Activity.
Topics: Androstenes; Biotransformation; Female; Humans; Laboratories; Nandrolone; Pregnancy; Progestins; Sewage | 2021 |
Dienogest-induced major depressive disorder with suicidal ideation: A case report.
Topics: Adult; Depressive Disorder, Major; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Suicidal Ideation | 2021 |
A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Topics: Adenomyosis; Cohort Studies; Dysmenorrhea; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nandrolone | 2022 |
Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN.
Topics: Adolescent; Adult; Amenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life | 2022 |
A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms.
Topics: Adult; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Treatment Outcome | 2022 |
Autoimmune progesterone dermatitis treated with dienogest: A case report.
Topics: Autoimmune Diseases; Dermatitis; Humans; Nandrolone; Progesterone | 2022 |
Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.
Topics: Contraception; Contraceptives, Oral; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Retrospective Studies; Secondary Prevention | 2022 |
Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
Topics: Adenomyosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Retrospective Studies; Treatment Outcome | 2022 |
Cost-effectiveness Analysis of Dienogest Compared with Combined Oral Contraceptives after Surgery for Endometriosis.
Topics: Contraceptives, Oral, Combined; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Endometriosis; Female; Humans; Nandrolone; Quality-Adjusted Life Years | 2023 |
Is dienogest a convenient treatment option for cesarean scar endometriosis or should it be treated surgically?
Topics: Adult; Cicatrix; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Treatment Outcome | 2023 |
Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study.
Topics: Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Quality of Life; Treatment Outcome | 2023 |
Genome-Wide Gene Expression Profiling Reveals the Direct Effect of Dienogest on Ovarian Endometriotic Stromal Cells.
Topics: Endometriosis; Female; Gene Expression Profiling; Humans; Nandrolone; Progestins; Stromal Cells | 2023 |
Dienogest Use for Recurrent Pyosalpinx as a Long-Term Complication of Cloacal Exstrophy: A Case Report.
Topics: Abdominal Pain; Adolescent; Adult; Bladder Exstrophy; Female; Humans; Nandrolone; Salpingitis; Urogenital Abnormalities; Young Adult | 2023 |
Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery.
Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone | 2023 |
Endometriosis features and dienogest tolerability in women with depression: a case-control study.
Topics: Case-Control Studies; Depression; Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain | 2023 |
Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study.
Topics: Dysmenorrhea; Dysuria; Endometriosis; Estradiol; Estrogens; Female; Humans; Nandrolone; Retrospective Studies | 2023 |